<SEC-DOCUMENT>0001144204-15-007485.txt : 20150210
<SEC-HEADER>0001144204-15-007485.hdr.sgml : 20150210
<ACCEPTANCE-DATETIME>20150210163107
ACCESSION NUMBER:		0001144204-15-007485
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20150210
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Shareholder Nominations Pursuant to Exchange Act Rule 14a-11
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20150210
DATE AS OF CHANGE:		20150210

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			SANGAMO BIOSCIENCES INC
		CENTRAL INDEX KEY:			0001001233
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				680359556
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-30171
		FILM NUMBER:		15594288

	BUSINESS ADDRESS:	
		STREET 1:		501 CANAL BLVD
		STREET 2:		POINT RICHMOND TECH CNTR.
		CITY:			RICHMOND
		STATE:			CA
		ZIP:			94804
		BUSINESS PHONE:		5109706000

	MAIL ADDRESS:	
		STREET 1:		501 CANAL BLVD
		STREET 2:		POINT RICHMOND TECH CNTR.
		CITY:			RICHMOND
		STATE:			CA
		ZIP:			94804
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>v401002_8k.htm
<DESCRIPTION>8-K
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>UNITED STATES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SECURITIES AND EXCHANGE COMMISSION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Washington,
DC 20549</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>FORM 8-K</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>CURRENT
REPORT Pursuant</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>to
Section 13 or 15(d) of the</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Securities
Exchange Act of 1934</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Date of report (Date
of earliest event reported)<U>: February 10, 2015</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; border-bottom: Black 0.75pt solid"><B>SANGAMO
BIOSCIENCES, INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Exact Name of Registrant as Specified in
Its Charter)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; border-bottom: Black 0.75pt solid">Delaware</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(State or Other Jurisdiction of Incorporation)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; border-bottom: Black 0.75pt solid"><B>&#9;000-30171&#9;68-0359556</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#9;(Commission File Number)&#9;(IRS Employer Identification
No.)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;<B>&#9;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; border-bottom: Black 0.75pt solid"><B>&#9;501 Canal Blvd, Suite
A100&#9;Richmond, California 94804</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#9;(Address of Principal Executive Offices)&#9;(Zip Code)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; border-bottom: Black 0.75pt solid"><B>(510)
970-6000</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Registrant&rsquo;s Telephone Number, Including
Area Code)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 1pt; margin-bottom: 1pt"><DIV STYLE="font-size: 1pt; border-top: Black 0.75pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Former Name or Former Address, if Changed
Since Last Report)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Check the appropriate
box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the
following provisions (<I>see </I>General Instruction A.2. below):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9;</FONT><FONT STYLE="font-family: Wingdings">o</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9;Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9;</FONT><FONT STYLE="font-family: Wingdings">o</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9;Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9;</FONT><FONT STYLE="font-family: Wingdings">o</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9;Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9;</FONT><FONT STYLE="font-family: Wingdings">o</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9;Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Item 2.02. Results of Operations and
Financial Condition. </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">On February 10, 2015,
Sangamo BioSciences, Inc. issued a press release announcing its financial results for the quarter and twelve months ended December
31, 2014. A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Item 5.08. Shareholder Director Nomination.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On February 10, 2015, Sangamo BioSciences,
Inc. (the &ldquo;Company&rdquo;) announced that the Company will hold its 2015 Annual Meeting of Stockholders (the &ldquo;Annual
Meeting&rdquo;) on June 22, 2015. Because the new Annual Meeting date has advanced by more than 30 days from the anniversary date
of the Company&rsquo;s 2014 Annual Meeting of Stockholders (the &ldquo;2014 Annual Meeting&rdquo;), in accordance with Rule 14a&minus;5(f)
under the Securities Exchange Act of 1934, as amended (the &ldquo;Exchange Act&rdquo;), the Company is informing stockholders of
such change.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Because the Annual Meeting will be held
more than 30 days from the anniversary date of the 2014 Annual Meeting, the deadline for stockholder nominations or proposals for
consideration at the Annual Meeting set forth in the Company&rsquo;s 2014 Proxy Statement no longer applies. Accordingly, if a
stockholder intends to nominate a candidate for election to the Board or to propose other business for consideration at the Annual
Meeting to be included in the Company&rsquo;s proxy statement relating to the Annual Meeting (including a proposal made pursuant
to Rule 14a&minus;8 promulgated under the Exchange Act, and any notice on Schedule 14N) must be received by the Company at its
principal executive offices no later than the close of business on February 20, 2015. In addition, the proxy solicited by the Board
of Directors for the Annual Meeting will confer discretionary authority to vote on any stockholder proposal presented at the Annual
Meeting if the Company does not receive notice of such proposal prior to February 20, 2015.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition, pursuant to the Company&rsquo;s
Amended and Restated Bylaws, any stockholder who intends to present a proposal at the Annual Meeting outside of the process provided
by Rule 14a-8 of the Exchange Act must provide the Company with notice of any such proposal no later than the close of business
on February 20, 2015. All stockholder proposals must comply with applicable Delaware law, the rules and regulations promulgated
by the Securities and Exchange Commission, and the Company&rsquo;s Amended and Restated Bylaws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Item 9.01 Financial Statements and Exhibits.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(c) Exhibits. The following material is
filed as an exhibit to this Current Report on Form 8-K:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Exhibit No.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">99.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;Press Release Issued February 10,
2015.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>SIGNATURES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Pursuant to the requirements of the Securities Exchange Act
of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">DATE: February 10, 2015</FONT></TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">SANGAMO BIOSCIENCES, INC.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 54%">&nbsp;</TD>
    <TD STYLE="width: 4%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">By:</FONT></TD>
    <TD STYLE="width: 41%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">/s/ EDWARD O. LANPHIER II</FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Edward O. Lanphier II</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">President, Chief Executive Officer</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>



<P STYLE="margin: 0"></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>v401002_ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<html><head><META content="text/html; charset=utf-8"></META></head><body style="font-size:10pt;font-family:Arial;color:black;"><div style="width:100%;margin-left:10pt">
<p style="text-align:center"><b>Sangamo BioSciences Reports Fourth Quarter and Full Year 2014 Financial Results</b></p></div><div style="width:100%;margin-left:10pt;"><div style="margin:0;margin-top:16pt;"><p>RICHMOND, Calif., Feb. 10, 2015 /PRNewswire/ -- Sangamo BioSciences, Inc. (NASDAQ: SGMO) today reported its fourth quarter and full year 2014 financial results and accomplishments.</p><div style="TEXT-ALIGN: left; WIDTH: 100%" id="prni_dvprnejpg864fleft"><img src="sf35903logo.jpg" id="prnejpg864fleft" title="Sangamo BioSciences, Inc." border="0" alt="Sangamo BioSciences, Inc." align="middle"></div><p>For the fourth quarter ended December 31, 2014, Sangamo reported a consolidated net loss of $4.3 million, or $0.06 per share, compared to a net loss of $8.1 million, or $0.13 per share, for the same period in 2013. As of December 31, 2014, the Company had cash, cash equivalents,
marketable securities and interest receivable of $226.6 million.</p><p>Revenues for the fourth quarter of 2014 were $15.0 million, compared to $6.9 million for the same period in 2013. Fourth quarter 2014 revenues were generated from the Company&#39;s collaboration agreements with Shire International GmbH (Shire), Biogen Idec (Biogen), Dow AgroSciences, and Sigma Aldrich, enabling technology agreements and research grants. The revenues recognized for the fourth quarter of 2014 consisted of $14.5 million in collaboration agreements and approximately $0.4 million in research grants, compared to $6.6 million and $0.3 million, respectively, for the same period in 2013.</p><p>The increase in collaboration agreement revenues was primarily due to an increase in revenues under the Company&#39;s collaboration and license agreements with Shire and Biogen. In the fourth quarter of 2014, Sangamo
recognized $7.4 million of revenues related to research services performed under the collaboration agreement with Shire, and $4.0 million of revenues related to research services performed under the collaboration agreement with Biogen. In addition, pursuant to the agreements entered into with Shire in January 2012 and Biogen in January 2014, Sangamo received upfront payments of $13.0 million and $20.0 million, respectively. These payments are being recognized as revenue on a straight-line basis over the initial six-year research term for Shire and approximately 40 months for Biogen. The Company recognized $0.5 million of the Shire upfront payment and $1.6 million of the Biogen upfront payment as revenue for the fourth quarter of 2014.</p><p>Research and development expenses were $15.0 million for the fourth quarter of 2014, compared to $10.8 million for the same period in 2013. The
increase was primarily due to increases in external research expenses associated with our preclinical programs, and personnel-related expenses, including stock-based compensation. General and administrative expenses were $4.3 million for the fourth quarter of 2014, compared to $4.2 million for the same period in 2013.</p><p>Total operating expenses for the fourth quarter of 2014 were $19.4 million, compared to $15.0 million for the same period in 2013.</p><p><b>Full Year Results</b></p><p>For the year ended December 31, 2014, the consolidated net loss was $26.4 million, or $0.39 per share, compared to a consolidated net loss of $26.6 million, or $0.48 per share, for the year ended December 31, 2013. Revenues were $45.9 million for the year ended December 31, 2014, compared to $24.1 million for the same period in 2013. Total operating expenses were $72.7 million for the year ended
December 31, 2014, compared to $50.8 million for the same period in 2013.</p><p><b>Recent Highlights</b></p><ul type="disc">
<li><b>Announcement of FDA clearance of IND application for Phase 1/2 clinical trial in beta-thalassemia.&#160; </b>In February 2015, Sangamo announced that an Investigational New Drug (IND) application for the Company&#39;s SB-BCLmR-HSPC genome editing approach for the potential cure of beta-thalassemia, has been cleared by the U.S. Food and Drug Administration (FDA) and is now active. This enables Sangamo to conduct a Phase 1/2 clinical trial of the ZFP Therapeutic<sup>&#174;</sup> in transfusion-dependent patients with beta-thalassemia major, which is expected to initiate in 2015.&#160; The trial is designed to assess the safety, tolerability and measures of efficacy of SB-BCLmR-HSPC. Sangamo is developing the therapy in collaboration with Biogen. </li>
<li><b>Presentation of new data at American Society of Hematology Meeting demonstrating broad application of ZFN-mediated genome editing approach to therapeutics for hemophilia and lysosomal storage disorders. </b>&#160;In December 2014,&#160;Sangamo presented new preclinical data from its first two proprietary programs for the treatment of lysosomal storage disorders (LSDs) and its Shire-partnered hemophilia program. These studies demonstrate the broad applicability of Sangamo&#39;s In Vivo Protein Replacement Platform (IVPRP) for the potentially curative treatment of such diseases.&#160; The data presented at ASH demonstrated the efficient production, secretion and tissue uptake of functional iduronate-2-sulfatase and alpha-L-iduronidase, enzymes that are deficient in the LSDs, Hunter and Hurler syndrome, respectively. Data presented from the hemophilia program demonstrated that
therapeutic levels of Factor IX, the human clotting factor that is deficient in hemophilia B, could be produced in a dose-dependent manner in non-human primates (NHPs).&#160; Studies in mice also demonstrated stable Factor IX production for over one year using this approach. </li>
<li><b>Presentation of data from Huntington&#39;s disease (HD) studies at Society for Neuroscience Meeting demonstrating reversal of disease signs and symptoms in animal models. </b>In November 2014, Sangamo presented positive preclinical data from its Shire-partnered program to develop a novel ZFP Therapeutic for HD at the 2014 Annual Meeting of the Society for Neuroscience.&#160; The data demonstrated that Sangamo&#39;s ZFP TF gene regulation technology can selectively repress expression of the mutant form of the huntingtin gene (HTT) which causes the disease, while leaving the normal gene largely unchanged, resulting in molecular and symptomatic improvements in several animal models and patient-derived cells that span the full range of mutations relevant to human disease. </li>
<li><b>Election of Sangamo BioSciences President and CEO Edward Lanphier as Chairman of the Alliance for Regenerative Medicine.&#160; </b>In November 2014, Sangamo announced that Edward Lanphier, the Company&#39;s president and CEO, was elected to serve as the next Chairman of the Alliance for Regenerative Medicine (ARM). Washington, DC-based ARM is an international organization that represents and supports industry, clinical institutions, patient advocates and other stakeholders in the development of safe and effective gene and cell therapies.&#160; Mr. Lanphier began his two-year term as chairman on January 1, 2015.</li></ul><p><b>Financial Guidance for 2015 </b></p><ul type="disc">
<li><b>Cash and Investments:</b> Sangamo expects that its cash, cash equivalents and marketable securities will be at least $180 million at the end of 2015, inclusive of research funding and certain milestone payments from Shire and Biogen but exclusive of funds arising from any additional new collaborations or partnerships, equity financings or other new sources. </li>
<li><b>Revenues: </b>Sangamo expects that revenues will be in the range of $60 million to $70 million in 2015, inclusive of research funding and certain milestone payments from Shire and Biogen. </li>
<li><b>Operating Expenses:</b> Sangamo expects that operating expenses will be in the range of $100 million to $110 million for 2015. </li></ul><p><b>2015 Annual Meeting of Stockholders</b></p><p>Sangamo will host its 2015 Annual Meeting of Stockholders at 9:00 am PT on Monday, June 22, 2015 at its headquarters in Richmond, California. Details about the 2015 Annual Meeting will be provided in a notice and proxy statement to be distributed to stockholders and filed with the Securities and Exchange Commission.</p><p><b>Conference Call</b></p><p>Sangamo will host a conference call today, February 10, 2015, at 5:00 p.m. ET, which will be open to the public. The call will also be webcast live and can be accessed via a link on the Sangamo BioSciences website in the Investor Relations section under &#34;Events and Presentations&#34; http://investor.sangamo.com/events.cfm.  A replay of the
webcast will also be available for two weeks after the call. During the conference call, the Company will review these results, discuss other business matters and provide guidance with respect to 2015.</p><p>The conference call dial-in numbers are (877) 377-7553 for domestic callers and (678) 894-3968 for international callers. The conference ID number for the call is 73428730.  For those unable to listen in at the designated time, a conference call replay will be available for one week following the conference call, from approximately 8:00 p.m. ET on February 10, 2015 to 11:59 p.m. ET on February 17, 2015. The conference call replay numbers for domestic and international callers are (855) 859-2056 and (404) 537-3406, respectively. The conference ID number for the replay is 73428730.</p><p><b>About Sangamo</b></p><p>Sangamo BioSciences, Inc. is focused on Engineering Genetic
Cures<sup>TM </sup>for monogenic and infectious diseases by deploying its novel DNA-binding protein technology platform in therapeutic gene regulation and genome editing. The Company has ongoing Phase 2 clinical trials to evaluate the safety and efficacy of a novel ZFP Therapeutic<sup>&#174;</sup> for the treatment of HIV/AIDS (SB-728-T) and NGF-AAV for Alzheimer&#39;s disease (CERE-110), as well as a Phase 1/2 trial of a ZFP Therapeutic for beta-thalassemia. Sangamo&#39;s other therapeutic programs are focused on monogenic and rare diseases. The Company has formed a strategic collaboration with Shire International GmbH to develop therapeutics for hemophilia, Huntington&#39;s disease, and other monogenic diseases, and with Biogen Idec for hemoglobinopathies. It has also established strategic partnerships with companies in non-therapeutic applications of its technology, including Dow
AgroSciences and Sigma-Aldrich Corporation. For more information about Sangamo, visit the Company&#39;s website at www.sangamo.com. </p><p><i>ZFP Therapeutic</i><i><sup>&#174;</sup></i><i> is a registered trademark of Sangamo BioSciences, Inc.</i></p><p><i>This press release contains forward-looking statements regarding Sangamo&#39;s current expectations.  These forward looking statements include, without limitation, references to expected timing of initiating clinical trials, anticipated cash and investment balance, operating expenses, revenue and potential milestone and royalty payments under Sangamo&#39;s agreements with Shire and Biogen, the research and development of </i><i>ZFNs and ZFP TFs, clinical trials and therapeutic applications of Sangamo&#39;s ZFP technology platform and achievement of research milestones and objectives under collaboration agreements with Shire and
Biogen</i><i>. These statements are not guarantees of future performance and are subject to certain risks, uncertainties and assumptions that are difficult to predict. Factors that could cause actual results to differ include, but are not limited to, the early stage of ZFP Therapeutic development, the lengthy and uncertain regulatory approval process, uncertainties related to the timing of initiation and completion of clinical trials, whether clinical trial results will validate and support the safety and efficacy of ZFP Therapeutics, and the ability to establish strategic partnerships.  Further, there can be no assurance that the necessary regulatory approvals will be obtained or that Sangamo and its partners will be able to develop commercially viable gene-based therapeutics. Actual results may differ from those projected in forward-looking statements due to risks and uncertainties
that exist in Sangamo&#39;s operations and business environments. These risks and uncertainties are described more fully in Sangamo&#39;s Annual Reports on Form 10-K and Quarterly Reports on Form 10-Q as filed with the Securities and Exchange Commission. Forward-looking statements contained in this announcement are made as of this date, and Sangamo undertakes no duty to update such information except as required under applicable law.</i></p><p> </p><div>
<div><table style="BORDER-BOTTOM: 1pt; BORDER-LEFT: 1pt; BORDER-COLLAPSE: collapse; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt" border="0" cellspacing="0" cellpadding="0"><tr><td colspan="2" style="BORDER-BOTTOM: 1pt; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 6pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt"><b>SELECTED CONSOLIDATED FINANCIAL DATA</b></font></font></p></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td></tr><tr><td style="BORDER-BOTTOM: 1pt; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 6pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">(in thousands, except per share data)</font></font></p></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td></tr><tr><td style="BORDER-BOTTOM: 1pt; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 6pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">(unaudited)</font></font></p></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td></tr><tr><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td></tr><tr><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td colspan="3" style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: center; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 6pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">&#160;Three Months Ended&#160;&#160;</font></font></p></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td colspan="3" style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: center; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 6pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">&#160;Twelve Months Ended&#160;&#160;</font></font></p></td></tr><tr><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td colspan="3" style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 6pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">&#160; December 31,&#160;</font></font></p></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td colspan="3" style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 6pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">&#160;December 31,&#160;</font></font></p></td></tr><tr><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">2014</font></font></p></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: center; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">2013</font></font></p></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: center; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">2014</font></font></p></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: center; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">2013</font></font></p></td></tr><tr><td style="BORDER-BOTTOM: 1pt; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 6pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt"><b>Statement of Operations Data:</b></font></font></p></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td></tr><tr><td style="BORDER-BOTTOM: 1pt; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 6pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">Revenues:</font></font></p></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td></tr><tr><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: left; BORDER-LEFT: 1pt; PADDING-LEFT: 12px; PADDING-RIGHT: 6pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">Collaboration agreements</font></font></p></td><td nowrap="nowrap" style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">$ &#160; &#160; &#160; &#160; &#160; 14,546</font></font></p></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt;
BORDER-RIGHT: 1pt">
<br /></td><td nowrap="nowrap" style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">$ &#160; &#160; &#160; &#160; &#160; &#160; 6,613</font></font></p></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td nowrap="nowrap" style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">$ &#160;43,880</font></font></p></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td nowrap="nowrap" style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">$ &#160;21,678</font></font></p></td></tr><tr><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: left; BORDER-LEFT: 1pt; PADDING-LEFT: 12px; PADDING-RIGHT: 6pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">Research grants</font></font></p></td><td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p
style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">406</font></font></p></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">256</font></font></p></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">1,990</font></font></p></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">2,455</font></font></p></td></tr><tr><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: left; BORDER-LEFT: 1pt; PADDING-LEFT: 24px; PADDING-RIGHT: 6pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">Total revenues</font></font></p></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font
style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">14,952</font></font></p></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">6,869</font></font></p></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">45,870</font></font></p></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">24,133</font></font></p></td></tr><tr><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 24px; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td></tr><tr><td style="BORDER-BOTTOM: 1pt; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 6pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">Operating expenses:</font></font></p></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td></tr><tr><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: left; BORDER-LEFT: 1pt; PADDING-LEFT: 12px; PADDING-RIGHT: 6pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">Research and development</font></font></p></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">14,991</font></font></p></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">10,778</font></font></p></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">56,744</font></font></p></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">36,979</font></font></p></td></tr><tr><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: left; BORDER-LEFT: 1pt; PADDING-LEFT: 12px; PADDING-RIGHT: 6pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">General and administrative</font></font></p></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font
style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">4,330</font></font></p></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">4,205</font></font></p></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">15,677</font></font></p></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">13,800</font></font></p></td></tr><tr><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: left; BORDER-LEFT: 1pt; PADDING-LEFT: 12px; PADDING-RIGHT: 6pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">Change in fair value of contingent liability</font></font></p></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN:
0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">100</font></font></p></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">60</font></font></p></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">230</font></font></p></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">60</font></font></p></td></tr><tr><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: left; BORDER-LEFT: 1pt; PADDING-LEFT: 24px; PADDING-RIGHT: 6pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">Total operating expenses</font></font></p></td><td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: black 0.5pt solid; BORDER-RIGHT: 1pt"><p
style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">19,421</font></font></p></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: black; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">15,043</font></font></p></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: black 0.5pt solid; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">72,651</font></font></p></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: black; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">50,839</font></font></p></td></tr><tr><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: left; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 6pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">Loss from operations</font></font></p></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 6pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font
style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">(4,469)</font></font></p></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 6pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">(8,174)</font></font></p></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 6pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">(26,781)</font></font></p></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 6pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">(26,706)</font></font></p></td></tr><tr><td style="BORDER-BOTTOM: 1pt; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 6pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">Interest and other income, net</font></font></p></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font
style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">150</font></font></p></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">30</font></font></p></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">364</font></font></p></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">82</font></font></p></td></tr><tr><td style="BORDER-BOTTOM: 1pt; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 6pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">Net loss</font></font></p></td><td nowrap="nowrap" style="BORDER-BOTTOM: black 2pt double; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 6pt; VERTICAL-ALIGN: bottom; BORDER-TOP: black 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font
style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">$ &#160; &#160; &#160; &#160; &#160; (4,319)</font></font></p></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td nowrap="nowrap" style="BORDER-BOTTOM: black 2pt double; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 6pt; VERTICAL-ALIGN: bottom; BORDER-TOP: black 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">$ &#160; &#160; &#160; &#160; &#160; (8,144)</font></font></p></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td nowrap="nowrap" style="BORDER-BOTTOM: black 2pt double; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 6pt; VERTICAL-ALIGN: bottom; BORDER-TOP: black 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">$(26,417)</font></font></p></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td nowrap="nowrap" style="BORDER-BOTTOM: black 2pt double; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 6pt; VERTICAL-ALIGN: bottom; BORDER-TOP: black 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">$(26,624)</font></font></p></td></tr><tr><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td></tr><tr><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: left; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 6pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">Basic and diluted net loss per common share</font></font></p></td><td nowrap="nowrap" style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 6pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">$ &#160; &#160; &#160; &#160; &#160; &#160; (0.06)</font></font></p></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom;
BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td nowrap="nowrap" style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 6pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">$ &#160; &#160; &#160; &#160; &#160; &#160; (0.13)</font></font></p></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td nowrap="nowrap" style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 6pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">$ &#160; &#160;(0.39)</font></font></p></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td nowrap="nowrap" style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 6pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">$ &#160; &#160;(0.48)</font></font></p></td></tr><tr><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td></tr><tr><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: left; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 6pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">Shares used in computing basic and diluted net loss per common share</font></font></p></td><td style="BORDER-BOTTOM: black 2pt double; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">68,607</font></font></p></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt;
BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: black 2pt double; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">61,871</font></font></p></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: black 2pt double; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">67,022</font></font></p></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: black 2pt double; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">55,974</font></font></p></td></tr><tr><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td></tr><tr><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td></tr><tr><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td></tr><tr><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td></tr><tr><td style="BORDER-BOTTOM: 1pt; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 6pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt"><b>SELECTED BALANCE SHEET DATA</b></font></font></p></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td></tr><tr><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: center; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 6pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt"><u>December 31, 2014</u></font></font></p></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: center; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 6pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt"><u>December 31, 2013</u></font></font></p></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td></tr><tr><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: center; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 6pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">(Unaudited)</font></font></p></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td></tr><tr><td style="BORDER-BOTTOM: 1pt; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 6pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">Cash, cash equivalents, marketable securities and interest receivable</font></font></p></td><td nowrap="nowrap" style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">$ &#160; &#160; &#160; &#160; 226,645</font></font></p></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom;
BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td nowrap="nowrap" style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">$ &#160; &#160; &#160; &#160; 131,814</font></font></p></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td></tr><tr><td style="BORDER-BOTTOM: 1pt; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 6pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">Total assets</font></font></p></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">243,212</font></font></p></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">140,838</font></font></p></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td></tr><tr><td style="BORDER-BOTTOM: 1pt; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 6pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">Total stockholders&#39; equity</font></font></p></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">206,633</font></font></p></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt"><p style="MARGIN: 0in"><font style="font-family:Arial;font-size:8pt;color:black"><font style="FONT-FAMILY: Arial; FONT-SIZE: 8pt">121,710</font></font></p></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td><td style="BORDER-BOTTOM: 1pt; TEXT-ALIGN: right; BORDER-LEFT: 1pt; PADDING-LEFT: 6pt; PADDING-RIGHT: 8pt; VERTICAL-ALIGN: bottom; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">
<br /></td></tr></table></div></div><p></p><p> </p><p>Logo - http://photos.prnewswire.com/prnh/20130102/SF35903LOGO </p><p> </p>
<br /><br /><p>CONTACT: Sangamo BioSciences, Inc., Elizabeth Wolffe, Ph.D., (510) 970-6000, x271; OR Varant Shirvanian, (510) 970-6000, x205</p></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>sf35903logo.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 sf35903logo.jpg
M_]C_X``02D9)1@`!`@```0`!``#_VP!#``$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0$!`0("`0$"`0$!`@("`@("`@("`0("`@("`@("`@+_
MVP!#`0$!`0$!`0$!`0$"`0$!`@("`@("`@("`@("`@("`@("`@("`@("`@("
M`@("`@("`@("`@("`@("`@("`@("`@+_P``1"`!;`9`#`2(``A$!`Q$!_\0`
M'P```04!`0$!`0$```````````$"`P0%!@<("0H+_\0`M1```@$#`P($`P4%
M!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T?`D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$!
M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$"
M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#^_BBF[N,X
M/^?Z5%).$&0C.><A2,C@D=3SR`/QI*2<^17<O1V^^UOQ)<HI7<DE9O731:[;
MD]0.X1CEL'TYSCZ`=./TJO-J$-M%)/=%;6WAA:>:>XFAAAABC7?+))+(X"1H
M@)9B<`#).*_*?]IW_@KA^SI\#6U;PWX,GNOB]\0[-+B$:-X5GMU\.6&I1EHA
M#KGBN5C#'"DBD/\`84O91CY8R>GT'#G"G$7&&84\LX;RNOFF-FTN6C#F4&]O
M:-VC!?XVCY'C/CS@_P`/\IGG7&.=T<FR^$7)2J2M.=K:0@DYREJM%&]VC]5)
MYX'C8&6(;D8IO4991MRRJ?OIR,D<#/6O%?B_^T9\%/@'I<>J?%KXC>&_!4<R
M*]I:ZG>*^KZA'YAA\RPT>QCEN+J`3*4+I"8TD95D="PS_,7I?_!07]MG]LOX
MW>`OA5X+\>K\*+#QUXKT_18M&\`PK;QZ?I[^3<:S=WVNWEE+>W8CT=-1E+2R
M+&3:NODJS)G[Q_X+C>&?"-G\#O@=K6I:?:ZEX_L_B39>&=-\8720CQ&?#\/A
M3Q'J>NQ>>L+*]E<ZA8Z1)/#POF-'(N"F#^O8?P'QN4\<\!\(<9YG'"U^,JC]
MM1P-JF(PU",G'GJ<RA!2YHSC[LYVY963L?SUC?I/Y=GGAKXD^(7`&1U:^`\/
M[06(S%<F'Q==J+]C2C2;Q7NJ49WDH4_>CK=Z_;/PE_X*6?LX?'WXL:9\(?A:
M/'WB/7=:BU&6+5$\(7%IHD=KIMG>W=S=7MW?743)9""UEV2B,J);JW4X+BOS
M:^*__!<GQCX=\4>(_"O@[]G'3]&D\/ZKJ^BW3_$;Q3?R:DL^E7L]E/'?>']&
MM+<:=>B>WDW1B]F3Y0ZNP8&MS_@A/\&--ET3XO\`QZU"QBGUF?68?ACX:N9@
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M3T?5E1FU:]LH9+MR&$=K!*9/WFTJ?Q!\:_\`!:G]K+6_$LFH>#['X=^"-`MK
M_P`FS\*3^%T\7.(9G#6]CXB\1:E>03WNIB,@?Z)!IJ2"1Y5#B+<?H#_@MYXC
M;PY_PS-\"=`*Z9X*\/>%=5\4KHMJP%J)[#^S?!_A4&-UP\-AHEKK$$2MU&IY
M)S\R_KW^QY^SO\)?!W[*GPFT*R\!>$[FU\7?"WP9KOC/[;HMC>-XKU?Q+X9T
MO6M6FUZ6[MI&U&)KV_G$8D8B&-$6-3M%?,X+#>''`G!.4>(7$G`5+B;$^(F.
MQSPF`G-K#8'+L-4480I/WKSFN:SDG+S5S[#,ZWC!XI>(F;>%W"'BC6X+P?A3
ME.7?VAF--2>*S',,73C4E*KR-6A&2]Y)\O+?>]C\2]5_X+B_&_4](\,Z)9?"
MSP=X8\66^OZ%+XP\6P:I>:U!J&@0WD;ZAI7A[PAJVC1IHU[>6_GK'+-J%RMO
ML+JK$K7ZP?M]_MT^,_V+H_AQJNF_!B#XE^#?&]SJ5AJ/B2^\92^&X=+U:S1;
MJTT"WB@\.7KFZN=*6XFCN)!Y(-JZ%-PP?YSOB/\`!+P[K'_!1G6?@3\.]"M[
M'PS??M!Z1HFFZ19@)9Z9H\6K6>HZU;0QP18@L+>"74B%5#LBBQ@D8K]*O^"U
M^NZWXZ^+G[+W[-WA^Y:%M9N;G6FM!EK<^(/&'B/2_!OA6^N(M^));.T@U@H"
M#D7S8#'BON>)O#?PQK<>^%>!R;AB.&R?B3`9GF^:81UYTU3P=6A2JX1*HI-I
MTDIQBG)Q6ME8_,^#O%KQEI^&7C9C\ZXXQ&8<0<.9OD^0Y3BHT</53QWUNIAL
M1&$9PC3^K5W.FZS<?;6:U>J/ISX6?\%K/V6O&)M;;QYHOC[X87\RPQW!U32K
M?Q+H4,T@*E+?6/#4DTTEL%R5>>RM2X!PO0']7?AI\4_AS\6O#%GXR^&_C/0O
M&GAC4$6.WUG0M1M[RU279%*]G<(C>9I^HQK)%YUM.L<T)=1+&K$"OY$U_96^
M%D?_``4JTS]E>Z?4+/X86OCGP]X8N5>]DDU75[.Q\$C69[2741L:WN=1N(52
M8J`(4G*P-E@1^FW_``5P^"'P@^"O[)'PUMOASX4TSX=IX5^,FGCPM;>%HCIT
M/V_7/#NK+XAO;R.!D^W7\NG:8))+AL7)DTZ.03*-Z/\``\?>%OAG/B?PZX>X
M.QF99+B>/Z5'$T8UHPQ>$H86M&4:3FVZ==3<H:PC)\L&G)\UXO\`2O"SQV\9
M(\'>*/&/B'@,LS_*O"NM6P=54)/"8ZKC,-*,*T8PIQEAI0BFH0E."E)QM&\;
M,_?4S(2Q4K,8"-T<9#O&Y(92^!E1Y9!YP",&F;8=I<DRN%VY7!EC1^=I&?O#
MGWP?I7\\O_!("X_;%\?)J/Q"UGXM:EKOP,T<:GX2@\*?$+Q%?>)]1U#Q1INE
M6CV8T6:ZTR6ZT;38)KJV%Q*-19-H,<5H9%D=]&P_X+(>/?A/\7O%'PL_:D^!
M^FZ?)X7U^\T+4]6^&VJZC>ZEHUQ;SM%:7\6@Z\7_`+=TJ6U-O<++#=VTHCN5
M/V7?N0?F^9^"?%M#BKB3A+A[%X;BO,.&:3K5UAKTVDM_<KRBTX)KVD5*35]V
M]#]FR;Z2O`]?@SA+C?BW!8W@C+.,ZTJ&&GBZ$*\%6H056-7VM#FYJ=2+?)-T
MX\RB[+37^A]>``.F!_*EKR/X/_'#X<_';P#H/Q*^&.NP^(_"GB&&=[&[A!BN
M([BSE2WU'3KVTGVR66IVMVSQ7$$JJ\4D+*P&!GU1;E6<H%;=UP1CY><MR/NY
MQS[^E?D%>G4PV+KX#$P=''864H5:4DU4IR@TI1G!^]!IM+WDC^A<'F&!S#!X
M;,,%BX8K`XV$*E&K"2E3JPJ*\)0DM)*2U5KNW0L45$)0>"I!YX)7/'ISS3T;
M<H;&,]L@XYQU!J6FMT=G]?\`#=UYK0=1112`B9E#@9^8+N`(."`3WSUS4)FB
M4A6D1"V0@<@%RHR=@/+8!R<9QU/'-%Q($=?D+E@<!0"2<'&<D<?X5_*'^U_^
MWG^TU^T#^TKK/P'_`&>_%?B/PEX:L/&FH?#?P?IG@*]DTC7O&WB72=4BT76=
M1U/Q#:SPSVUH;YRMO&DMLEK%`;EWFR\<7W_AUX;YQXD9ECL%E6(H9=@\KINO
MC,5BVXT,/27VY-)RLVG;2WNR['Y!XO\`C'D/@]DV!S+.L)7S;'9Q7^K8'!X2
M/-B,16M!^SA'=R7M(7LG\2LC^K;SX0'/FVYV`LX5U<H`"26522!@'KC^E/MY
M8WE949&(4YV[B05.",]!@D\=:_EQG_X)\_\`!5GPM82^)M#^//B&_P!4C@^U
MOI>F?M%>/+G4I-D3N(C%K<L-C-,%#;5$[*S``G&2/Z.?@98>+]#^$'PQL/B+
M?7.I^/+#X?>#['QE?7=P+NXNO%4.@Z;%XAN9+H,?M+R:LER[N223SWY?&W!&
M3\*4L!7R?CG+N,H8R34HX)XASHM)/]XJB5K]-'?5Z&?ACXD\5<<XG'X3B/PM
MSC@!X-*5.ICYT94Z]VK1C[./Q]7&_,D>QT5GOJ=M!")[MTLXRRKNN)(XTW,,
MA1(6VLV>.">0::=5M=OF(PECW*IEC9'B&\.59W1B(UPA)+8`R,GFO@'&2BIN
M+C!_:::731MJR>JT;/UYUZ2J*DY_OGM#5S?I!>\_N-*BJC7D:#+#:.#RRD[3
M@;B`>!DX/T)Z#--:]1!N92%`)=R\:K&.<;V9P`"!D'H?KQ4\RY%43YX2M9Q]
MZ][-<O+?FW6URI5*<4VYI*-KZ_#?K);Q2ZN5DNMB[167!K%E=,4MI8[AE!+>
M3-#(%8%E*$QR'Y@0,CMN&:MBXSD&)Q@`]CR1NV\'AL?YZ43?LW.,XN#IJ[3B
MT[--[-:Z)[7?3<FE7HUX\]"M&M#O"2DM'R[Q;5[M*U[_`"+-%9-WK>GV*AKJ
MXCMU9D1&N)(X$=Y&"K&)9&"^;U.S=O(4D*0,U,NH(REC%*B@'YG``R`K8SGC
M*NA!.`=W&<'%\D[1?)+EGK%V=GML[6>ZTW$\103JKVL>:@DYJ]W!2;2<DM4F
MT]7VU-"BJ9O(QD[6VCH^4V/DC8$;=\Q;)P.O'..,P7&K6=I&\EU(ENJ'#F:6
M%%7"[F+.T@"J.Y)`I14IS4(Q;G)72L[_`);^6_D.M7HX>FZU>K&E2BKN4FE'
MI]IZ/=;,TZ*JI=I)MV*S!^C`97&!D[AQQD9&<CTI);R&%6>4E`K%1G'S8[CG
MIGCFE]IQ6LEI9:N^FEE=WU6GF.56G"$JLIJ-*"3<F[1L]GS;-/NG8MT5G/JE
MM&&>1@D2KO>8R1[$7G#/\_RJ<'![[3Z4MMJ5K=H9+>19(@VWS%9"N3MQDJQV
MY+`#.,]JIQG&+G*#C".[::2]6U9>ER5B,.ZL*$<13E7J1YXP4XN<H_S**;;7
MFD:%%9DNK6,$@BEGC21ON1F2,2OR`"D1?++D]>GXD58^U`OL$;$%2R,&3Y\$
M9"KNR3R,\<=\<94E**C)Q:C.UG9ZWZK35:[K0(8C#U)5(4Z\)SI?$E.+<?)I
M.Z?DU?R+=%4_MB`J'1T+9.&Q\JC)W.0?E7CO].M01:O93RO!#*DDL7$B))$S
MIZ!D#[LD<@8R00>XJ;Z59*,I1HVYFHR:5]M4FGOK:]NHY5Z,948SJQISKJ\(
MS:A*2\HRLW]QIT5`LZEPF""Q8+DKSMQD@!O?GN.X%3T)IN233<=';H]_R->_
MD%%%%,`HHHH`J22[8\_*!@GYR0HP>I(!(Z]@2?3GG\__`-IK_@I'^S=^S#J,
MWAOQ7X@O_%/C6U7S;GP1X%L!K>NV*.I%N=8D^V1VVB%W*`+<3;V$@8QH#7D?
M_!4G]MC4?V7/A;8^#O`=['#\7_B?%>V6@3Q@RS^&O#-JAAUGQ*858-]M9I!:
MV!!W&[9Y$5FMMC?D5\.O^".'[3WQ;\%VGQ)\4>.?`WA37/&=M!XFMM'\73^*
M-:\2WT^M0QW@NO%NHP6LWEZE(K1NY7=*#<G[20RA#^]^&GAEP77RG"<:^+/$
M4N&.$\?6]GE]&//&MF"B^6K.+492IT:4O=E+E<G-QY597?\`*/C)XS^(.!XB
MQ/AQX(\*1XPXVRS"T\5FE>:A*AEU.O;V,)-SC&6(J*[C3;LEJT]C[P\2?M2:
M%_P51^%'COX#?`OQ+XT^!'Q0TNT'BN70/%LNG6FG_$GPQI\=[8ZAX7FUCPMJ
M=V;73FDU2*6X1WBD22W@D:"YL_M9M_P=^"G[-?BGQQ^U5X5_9C\:VUUX;UJX
M^(EUX3\;?9Y@M[I$&@2ZA?>)I].DVRI;W#Z7IUQ+:2IY\&ZYB=7N8"K/]8?L
MH>`/B7^QY_P4>^#WP]^)&G6NG:A=Z\?#<\]K="^T;7O#7CS0=4L=*U+2[T01
MB\T^XOWM`5VX\V)D?YH\+](_$&>#X)?\%L]%U?42(-+\7>-_"]Q]I8[@$^(G
M@-_#5K@D=3K=Q`I)Y_?>F*_IK(9Q\-,7QEPIX;YHL;PSGG"^.S_):GLJ=3%2
MQ5%SH.D\4TJM=0C"51.6RM;8_BOBC#X[Q6P/`O%OBK@ZF#XPR+C'*^%>(Z+J
MSIX=8*K*%;"5I817H82LX5I4Z[H<L*UE.47))KS+PAX`\(?L<_\`!6WP+X&T
MNUN+#P)9>)O#FB>'I-1N9]2>.U^(7@]=-LK^XN[N0&X,NM:E"DCAE51++@+Q
MM^S/^"]EO<3_``G_`&?KNW_X]%^(WB.T>4`JB3WWA1Y;1"%X\XVT5T5/3$1&
M#7B7_!;WX8:QX.^*7P3_`&@_#<4]G!J5C%X5U'7;96$>D>*_`=ZWB'PU/)M/
MS75QI.HWAMR/NIX3?<.1GVG]O3Q8W[5W_!+[X9?'>UAMCJ&C:Y\/_&'B6VL>
M(-%\0QVNH>`_&ELI<[OL,>I:S*\&224`W=`:^,P6-GF_$'T;_%>OB/KBQ$?[
M&QM:4FXQQT)5(J55O[6(J5)N#=F^6[6MS]#S#+UP_P`'?2W\%</A/JE?`5*O
M$6789)*=3`5*E":A37VI4(4Z<JJ2<>7GM)['1?\`!#+XI:+J7PC^*WPF6X@M
MO$WA3Q_+XU6R?_6W>@^*M-L;&&[B0R`RPP:QI=W')@?)'+$&^=@Q^(/^"YVA
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MRJ4E2G*%248MPDO>7O1OQO\`P6+U&7Q[H_[&GQMBS]A^)?P-N98Y(T;9;W+P
M^&_%*1ER2$+0>+$VHS%O]`DY^4FOW_\`V%_%T'C7]D']GW6(Y!((/AGX8\/7
M#;@SM>>%+*#PW.SD,1O,ND2%O4MP%'`_$;]H_2+?XN?\$</V=O'EM''=ZE\)
M=2\*Q3SQ@"2VT^UGUGX?ZE:.YY^S-%>V#$=-UM%S\HK[(_X(E?$[_A)_V8?%
M/P\O9]][\*?B)?V-K&[L\R>'_$\#ZW83S''!.I1Z^B]O]#'K7Y%XBY=]:\!*
M2IQ4L3X:<3YAE]2+WCAY5:L8N*3=HSO3:4K;H_??!_.'E?TG,:JD^?"^+O">
M3YGAY-W]JZ."H*HVW:\O:4J^U]))_P`UOAG]B/PU#XX_X*[_`!SU^_C267PA
MXS_:'URS$N"8KFQ\5S^&+&4!P261-1.,8P=N/ER#UG[>^H)_P]L_9HAU)@;*
MRO/@8(1+AH/)F\:ZFZ.V\$!_M[Q\C:#GD$\U[Y^SY^S7\8/@W_P5;^*/C0>"
M=6E^%'Q"T[XA^(X/'$5L9=`,/C"^TS79[!]1MV,<.J1^)[-(6MY!YNR02XV2
M+7RI_P`%G)+CX<?MB_`WXJV,!D>S\#>$=<LY`WRW&I?#_P`=:CJ+I\IZF.ZT
M\\<'R1ZG/UV29C@.)?&#(</E^90Q^%Q?`LL'1=-\RI57ETYNET_>PE!QDEU?
MJ?`9]D^:<(?1[XDQN<Y74R['8'Q(ECZ\9QM*O16:4_8U$NM-<T7>36BNKGCW
M_!23^U_V?_\`@I-%\5M-2XC:34/A3\5].:$%)=5CTV'3M.UNT1UP,R2>';BV
M.T@[;R0%LD%?TB_X+17]G\0OV+?A3XZ\-746J>&[[XJ>!_%UAJ$`9[>]\/\`
MB?P1XPM+&]B^4%893X@TXKD`XN%'45X-_P`%N_`-CXQ\'_`']ICPE/%>^'M1
MTR]\&7=^#\ESH_B^P'C?P/J\1P-EDD</B*.0YW%M1M",;2:]0^&T"_M7_P#!
M'36_#A\RY\0_##PMK&GV,"N#=KJ/P?U9M?T6WB&W"W<WAFWLH%P,!KM!C:`!
MSX?&X2?"?T<O$"O)2Q7">8_V'F-_BA1<O9P<NB=-QE-*3BN6:LV['1BLMQ=#
MC3Z6OA-@VY8;C;*Y\0Y;RJU.I6Y5B*DH=9*IS<MXQE[T6GH=O_P0U\76FI_L
MV?$/PKO"7_A7XM:K<S1!E$ZV'BC1-`OK.X.#D1-<V6J*I&T'RB.2":_/G_@H
M3X9\&>"?^"H?A76_'6AZ7JG@#QGJOP<\5>+-*OXG73=0TW49[7PEKEQ>CS5$
MNV;2=08C(7;`FX'YMW)_\$9OCA)\-OVF)OASJNI+%X=^..@PZ%+"Y9;9O%OA
MNWU#5O##QL0=DLD,NKVHZ`I>DMDA2OH7_!=32_LO[1WPOU%#_P`A7X.VMM(X
M^\\NG>+_`!,8W)'1PDSX(QRV>M?187(\7D7TIN*\L<Y4\O\`$+*\?4HU$Y+F
MCCJ,?:*+_FI3I2Y>5Z:.]SYG,N*<%Q)]"S@K-:5"G6S+PNSO+,-7IM)N#P.*
M<)-KM7PV)IM\UN9)WZ)_:W_!63Q)\8OV8/`7P(UO]FGQ3=_"3X:Z=J_B+PIX
MC\/^`XK#P_IR:Q?Z?::KX0GDL;:Q:,VH;2O$*R?)^\ENX@P)8AOF7]E+_@M/
MXS\.:EI_@_\`:FTJW\6>'Q^Y;XH>'K"/3_%.BO%)-"L_B?P_:-]G\06/[D>;
M+`EA=0AM_P!FG`./MSX_V=Y^U9_P20T_QE?2#6/%MG\)O"OCZ_N3L<S>)O`(
MA'C"Z,C#Y5>72]=9FQC@\8)%?G5^PG\#?AS^W;^R;\1O@?XB@TC3?BW\$-=&
MN?"WQRT,<>K:=X<\<1:EK6E:;J%P`7UGPC-XCT34X+A>1%Y22H%>%"/D^$,+
MP+BO"3-L)X@Y#'%U>#\\Q&7YAC\-"*S'"QQ%50AC'.T:E>E"J^64*M23<>9Q
MC*249?;\=9CXH83QWX?QOA1QG5RC#\<<-X?-,KRJLYU,MQWU>C[6>7NE4JRH
M4:M6FGRSI4HQBVGSQW7].?P_\?>#?B9X6TOQIX`\0Z9XK\+:W`EYI.MZ1>PW
MMA<I)@-Y4T8W1S*Q*M%(B.K*595->@1`B-0>H!Z*5[G'RGIQ7\:W['/[47Q/
M_P"">_Q_U7X6?$\7]O\`#M?%K^&OBGX-^;4(M"U&:X%H_C#P\J/B::%UMKIU
M@&[4[>*2.%#*'-?V)Z%J^FZ[H^EZUHU_:ZGI.L:=::II>IV%U#?Z=J.GW]O'
M=V=]87UN3'>64MO+%)%,A*21R*ZG:17X#XJ>&.-\-\TP;ACUG/#>?4_K&78Z
M";I5Z=HMQ4FE>I!2CS6]QJ491=I)+^L?`GQHRSQAX;Q-=8!9#Q/P]4>&S3+)
M2<IX.LI.-_?4:BIU)1FTG'W91<6[HVJ*A3/_`#TW?-]<\$X]AU_*IJ_*T[^3
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MXNX#A]9;Q%/A;C+@[$/,,HQ<=>3$?NU[\?MT[TJ>D>:<6KJ)^3_[.?\`P67^
M!'Q5?1?#?Q8T?4O@UXMO;BUL)-1NV&J>`)+V]ECAMG_X2*UE\[0TGE8[([^U
M1(BX$MUU8?L+;W<6K:=;W^F7<-_;75L;BUE@D2XM[M+@/)!-#<HQ5XV;8R,K
M%"J;E=@!C^5C_@K!^Q1\!_V;[KX=>-?A'=)X;3X@Z_K&C:I\)YKI]0MWM+73
M)+\>)_#<=QN:TT6.YFMK*]MCNMR^MV0MMH1PWVG^R]^U1XM^"G_!)6]^+5XZ
MZSKW@>]U_P`!_#Z;4V>6WE@NM?30O#(N_-D&^PLC?SO%`#R-/$"@!L5]YQUX
M6\%9OPSPKX@>%$,3AL-Q;F%+`_V?C'*C*%:=1<LH3E?]VJBY9OGE=7LTKH_(
M/#/QPX\R'B_CSPK\;*V$QV/X,R>MF=3-\MH3FZF$I4U*?UFIS>Q=;V<E*G)T
M:4^>T)*Z=O'-#_X)$_M0_'>+_A*?VI?VE[S3M?N1"VFZ9=VVN?%C5;<-*XC:
M]DO]>TRRTJ`"3/EVZS1JS2$[#DGY&\4Q?'[_`()._M)>%O"MO\2K_P`1>`))
M-.\73:?IMWJMMX/\9^!+_4+FP\00WOA#4+Z6VT/Q&DNG74;/%<-*LES;21SM
M%N#^R?LF?`']IS_@I0WC3XF?$_\`:I\?>&_`FC>)+K0;NUT74=5E;5-:>QL=
M3U&PTWPH-2@TW0]&BL=7LPC,DD[$F*16C137Q?\`\%!?V;_"7[*_Q<TSX8^'
M/B;XA^)\R>`[76]>O_$8L4O?#M[>:CJ0MM)!MKATLX#I$-K/LD95)U=GQRNW
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MC^)-V(8_-D^-6I!I"H+LL/@_P@D*,S<LJ(H"YSMY(`))/Y)PGFW^I'T=,YSW
M+<NP=;/<#GTL+@Z]?`TZL\%+]U"-2BYJVT6N65K:22U:/W/C/A]>(GTM,CX<
MS3,L5A.&LQX9IXS%4L)BJM.&,IJ%2=;#3]G5A>G5E)*I4C%RO=)I),_%CXA>
M%/V@/^"7'[25EINA^,56YM[32_%MG<>''U"V\,?$CPO/?26\UAJ^@3R+YOFS
MZ?J5M<Q3&217M8VAG3JW],?[6_[8%G\&/V0G_:`\*0Q3ZGXS\/>$)OAG%?1H
MT)U+Q[;V%UI5W>6S2JLL5I973SR(C`A8N,C-?BK_`,%S$9_VDOA4X*`K\%].
MFR`%):+QIXFD##;T;=$O_?..F<_0'_!1?2;V^_X)8_L?WEDLLEKH=C^SQ>ZH
MH.56VNOA'>V*/S]Y1=WUJW/&Z,$CU^HXARW*/$+_`(EQS[B+!8>GFW%F+=#,
M?JM*,(XBG"M"TJE*FK+GG"SC:W*Y)6O8^6X5SC._">M]+_A'A3&5:F4\!8*%
M;*Z%6M.L\![6#IQK4IU6ZC=.,I/WG\4(-]U\!?LU_LA_M&?\%)O$GB/XL>*O
MBK=Z=:>&]2CTK4OB7XRGU?Q)KDNM2VRWZZ!X4TJTO[8V=C:K+IL\R07-K9M%
MJ<:!%D1WKDOVR;']K;]F/7O"?P%^)_QB\7>(-%\(6NO:W\.?%VA^)_$VG3:[
MX<\52:7:W5M=WPU47*"RN?#4`2RNI+@VIU&06]S-`P"?LY_P0_\`'?A?5/V9
M_$_@&RFLXO%/@[XBZY?ZWIL;EM0DTSQ(EC>:1J<L`'[N"20WL"^BZ<J_=``^
M&_\`@N=XU\,:W\:?A#X4T.]LKK7/!W@+Q$?$\-FZ326"^)=9TN?1K/52@S;W
M+6VF7DD$;DXCDD*;5)S]5P[QCG&<?2%QWAWF7#N75.%,AE6IX7!K`4J;PBI4
MG.C7C4C'GBJWNQC?2TK:7U^'XI\/.'\D^BMD/BIEO%683XXX@]E/$XC^TL3!
MXV6+QB6(P\DJTDI4'*^D9-\LK[G[<_L>W/B#7/V&O@[<Q7VH7GB?4/@W;/:Z
MK<7LD^J3:U<Z5=0V=V]]=[V-YY[(5FD,A#J"5(7G\B]%_P"".O[17QUT^U\7
M_M/?M++IOBUK>.YTW1)8-:^+-_I33Q+++_Q-=<US2HM%Q(2/LUE;2J.IN"Q-
M?83_`+0VN?LP?\$H/@]\3O"5M:77BY_AQX'\+^%AJ$27%C9Z]K]U);6NJW-M
M*P6Z2VMUNIA#D&4PA,U^=G[)G[*W[27_``41\.>(OBS\7/VJOB-H_@V'Q#>:
M':6MCK.KZI=ZWK%H()M5>#0UU.+2-`THB='C\J-[B(/Y;*,!C^/\(X3B;ARA
MXB\:X?B/!\"<.4\ZGA:F85<O_M&O'$TJU6+PV$H2BU&"53W];Z*R25S]YX^S
M#A/BFKX/>']7@[-/%#B^/#U/&TLLHYH\OP4<'7P]%K'8RI?WZMJ4XTYN-[N5
MW>23\>\.^(/C_P#\$O\`]KCPG\*;SX@S:U\.[K7/#EQ<^'K*[O8?`?B/P9XJ
MU)[*YU6T\-37(M_#WB2U0.[&!5D,EN"3)"61OV`_X+2>)=?\.?LJ>%M8\+>(
M==\.:@WQ?\*12ZAH&L:AHUV]F^C^)9)[>6YTRXB:1&2-V,;$Q,T2;T8+@_@1
M^V1\!_#7[-/[2FG?"SPW\2_$/Q232AX(O/$.I^)19F^TK6-:OYKY]$D-E*XQ
M'I3VCA3C;YN!7[M_\%NHXQ^R+X2C7<4D^,_@T.I(QEM!\4#80`,<%_\`OIA7
MZ-Q/E^2YCXB_1PX@=:AG=3B?VGUW$?4H9:L737L90J5\,ZDWSR]O;FDU>"2V
MB?DW!6:9UDWA-]+'A6E7KY/@N"G0CAL//,O[2JY94G.I"K1ABHPBG3A*BTN3
MF]Z]F?F!^RY^SG^UA^W]\'[OPQ<?&VZ\)_!'X;WVJ:!9QZ]<>(M?;QAXQNA/
MXB>/5;*+4%FU>VC;6[6![F[NG6"(1PVEG<M#(B?,O@/XH_M-_L+_`!K\<_!;
MX?\`BF<^(++7=9^',GABVN;W6/"VHZ[JL"Z9X?\`$&C:/>/''!J<4]_IUU:2
M^1$WFRA;JW8;H!_0/_P1<MX_^&+=+81K&\WQ*\?2SSQD!I)TU00!V)'S'R88
MU!_NH!7XP?&:&WE_X*\26LT:O'+^U7\-%>%P60J=<\$!T.>H`P,=,`5[O#?%
M,LX\0_&KA'-LFR^KPIP[ALQJT,#'`T)PG/"U;N52K&/M)2J2<IN=W9I.RO<^
M8XNX(_U<\)OH\<>Y5Q!G%+C?C3'9=AL5CEC<4O9T\724HJE#6GR15DK:O7?8
MZ+]KW_@GC^T9\(_A;_PU/\5/C5:?$7QG:7NBMXYMI+S7W\1^&)=7N%L]*DT'
MQ;=WK?VB([EX4F^S)81PO_QYM=@"0?K[_P`$B/VA/&_QK_9U\36?Q$\0WOB;
M7_A9XQG\*Q>(=6N&N]5U3PQ-I%EJ>C_VIJ+OOO-0A$T\1N'P[1Q)YF^0-(WJ
M'_!5U?\`C!?XPN4(\N7P?@[]PBQXRT([5'9<\8.1A1D&O@/_`((J:?=ZK^S9
M^U3I6E8&HZGXI?3+"1B4"7=_X#GMX-S(P*+]JFC)(Y`&01Q7Y9F6=5?$7Z/&
M;<0<5T<'#.\@S_"X+"XG"8&GAYT,'6GATZ*A0CR2HPC7U<VI+E4GK9G[AE/#
MN$\(/I29)PYP=7QZR;/^&<9CL30QN*Q.+C6QM&GB)1KN6(U5:4L/LER^]TO9
M?)W[1G[6O[1/[>O[1]S\`/V=O$&J:/\`#K4]>U7PAX5TKPSJ5]X>T[Q9I6CR
M7=MJ7C7QOK>FAY;WP]+`ES/%;R%87M9+93"9C))+=^*?_!*7]HG]E7P#?_'3
MX6?&'3M8UGP1IU[XD\66GP^MO$G@'Q)HVD6$<;:E?:%?V]X$\5"*'[1-,DAT
M^0QJ?)CG()/B_P#P2<UC2O`7[;GA#1O%\<>B:Q>Z1XN\%1VVKK'!/!XABL'6
M/37*J,7$KV5X%VD#?;L`,<#^J[]HWQ9X>\"?`CXO>+?$-Q;6.B:+X`\4M=&Z
ME>V^TS2:+J>G6=@)>"D\UU=V,,17!#W/!!YKZ/Q&XSS+PAXLX#X!X!R3`4^%
M,1AL%+V5;"0K?VU'$SC"M4K2JQ4I-J]E"THR2W3M'Y'PEX$R;QUX*\2?$SQ*
MS?-JO&F#QF/4:T<UQ>%64/"TJE7#PI8>-J45%QBFI-Q<7;=W/S<_X),_MX>)
M/VC]+UOX/_%G51JOQ/\``^DVFOZ/KMQ%''>^,O!;R6]D]]>-&1'<ZQI]_=6D
M=W.L<;S1ZO9LP9TF>3]K:_D._P""(NCZO?\`[7T^J6L+R6'A_P"$_B1M7N%*
MK';VM_J.CV.G6[KCES>RRJ0./]$4D912/Z\:_$/I#<,Y)PKXHYUE^00A0P.(
MA0Q#HTX1A"A5K4U*I1@HN2Y8RNXV=K.R221_3/T2>,N(^-O!K)\RXIQ53'YI
M@J^(PBQ%6[G7HT)J-*I*3^-N#2<^K3OJ%%%%?B!_3(4444`?R6?\%O[3Q%#^
MU/X3N]0C=]"U'X1:,?#DUP9$M'_LW7_$2:K9[E`9Q%>3K)/C)$>L*PR,D?NW
M^PI^U]X(_:G^$'A[5K;7].'Q,T3P]IEA\2/"KB/3]3L_$5G:16VI:]:Z8TI:
M70KV\VS6[P[XX1>I"[+(=E='^V+^Q_\`#W]L7X<GPIXN5M(\1:'/)?\`@/QG
M90Q3:KX:U:9##=^06.V[TN[@$<%W;2?)MC5U_>JI'\I_QC_98_:O_8/\:6?C
MR:/6=&M=*NW@T'XP?#:\U"31&=I6MDLK_5;.**70KJ5C&ILM1CA64@QE73)K
M^P.%J7`WC9X7\-<`X_.</PCXA\'-T\%+$54Z6.IS:E+D2CR*%5QC[1)^UC.*
MG'2\)?YY<9XGQ&^CCXQ\:>)V!X=K\:>&7B+*C7S!8:-7ZQ@:M*]*#J)PYE4H
MN4Y4[VH2IR2DXOWU^\G_``48^`GQ&\6_M+?L0?&_X:^"]7\3CP/\2]$T'XBR
MZ'8/>WFEZ"GC;PGXAT;5-16)MUKI$-JOC7S9BOEQ&Z_>.F]=WP+_`,%P-$U+
MPG^T3\#?B?I$YTS4M2^'RQ6.HP@?:8M>^'GBRXU2UOD8'GRH_$M@Y]HAC)R*
M^GO^"?'_``5;O_BAXDT'X&_M%6NGVGCG59(]+\%?$?3H;;3+#Q3J;H570?%&
MFH$CT7Q+-<(_V>:%3:W3ADG$+[)+C-_X+T^'[&Y^&/[/OB_RE-YI?CKQ)X6A
M90G[S2_%/A@ZE?,H&!L,GA:Q"<##2@849QT>'U/C?@?Q@\-N`>,\FC1QF08+
M-\MH58MR^N87,88FNJM*=W3G3IRFX46HWY>7VD5*+YL/%2MX?\?^`GBUXG^'
M>;U<:N(<;E&9XG#M1A6P>.P'U?"J-6'+STL0X>_-*4X-W<*DE))?2O[7FFP_
MMI?\$T'^)6CVD4FOS^`_#/QQTNQL7%T]AKGARQ?4?$MG8W"$DW<6GGQ#;Q,"
M=YM8USC-?GU_P2G\26'QH_9]_:I_8K\37%NTFN>$]8\8^![*]C98$L_$"2:7
MK4MI;@9AT_3_`!@OA>\C3'+:Y(PSAL>)_L\_\%;-2^!W[/WAW]G_`%CX#6?Q
M#TG3-%U[P[)K]]\3)]$EU+3M3NKY[N$Z%-X#OEG\M=3O(O+%P`Y@5,J#D><_
M\$A_%LWAG]M?P'ID2FSC\3^'_'?ABZMQL=8VF\/B_MX)2D4:;X[S0K10NQ?F
MAD+QHVW/U.%\/>*.'?#+QCR'&X+^SLKX:S&&<Y/4E6I5'&6$K5)P@HTYN<)/
MV2O=4W[S=M=/@JOBIPAQAXQ>!/$>68V6.SOBC*5P[Q/"="I24'C</"C3JU)S
MC&-92^L57/E<E>E!JVJ?B'[+GP,C^-?CKXE?LR^)8K7P[\3-4T3Q1+\.]8OU
M6WO-$^+?PWFO8;SPOJ=VA8IX<U6R_P"$AM;L1%VC>"WO(`[0)G@O&/Q3^(F@
M?"#Q%^RA\2-+OTC\`?%&'Q/X:L]3=$U7X>>(]/MO$>C^)O#H@C=DGT.ZCU22
MZ\M'>*&ZM(;BW>2.3>/LOX_,WP%_X*TRZ_I#IIL,7QW\"^*UDC)1&TSQW)H,
M^O!DP%19EU6^13WCNYBQR%W>\?\`!;C]G6U\&_$CP3^T!X;TG[-I/Q)2[\*>
M-C;A%@'B[1;3S]%N[AU0$RZAH*:A$S<L6TP;N.:_6,OXPP^9\>^'^#XAA"ME
M_B'E%#.,NJ3NY87-L%A%]8C1EM&&(4X\L97?-=)WJ3YOP[,^`,5EWAKXDX_(
M%/#9[X29SB\BS-0M_M>28^HU%XB%FI^RJT)VEIR4W#=PC)>@?L*Q1_%K_@E'
M^UC\,YXEDG\&?\+*GLH9")2LEOX9T[XE:3LD8X!'B!9F!SD;CS7CW_!#;X@W
MVA?M'?$KP`))/[)\?_#,:K-:(.)]?\$ZM:MHLA<C"B/2=9\3IR0";U1UQ7KO
M_!%EH]8^!O[:WA&X=I+232O#T\T3<H&\0^#?&FCW?'/+1:+#GCD*O7H/B;_@
MCW>S1?MO>`/)(`OO"GCR&<.=B&(>%=0N%W2YQ"!.L+%BKX\L[5+%:_/<[RW#
MU,N^EAD,J:EAJ%3#YA2C)I*%=8.%=M.UDI3C=Z7;T33/UGA;-L1A\W^A%Q%&
MHUF&*I8S*JE77F>$CCZF'ITW9-N,(5VDG>RBME<_LHA:)6)VA65O+#!&W%`.
MA^7I@<'H>,5_/S_P7K\"I>>!/@+\4H5B$NA>+?%/@6=MIW21^+=(LO$&GLY[
M+%<>"K_'H;X]S7G/Q5_X*V_M@_#SXW>(O@[/\!?A;I>OZ5XKM_#6G>#M1N/%
M'B'5]7NM4EAA\/6EOK]CJUO;22W4%Q8,76VE"->H=S+]WWC_`(+`ZSXIUC]A
M;X4:A\0O#FG^$O&NM?%+P6^K>&K+53K=KH>L3>&O%%UJ.FVNJF",W7E6J7L>
MXH-CYCRP4N?PSPLX$XL\._$WPASO-XT*>#XEQ"EA(PQ,*TJ^'J8:3DIP@^;D
M2FH\VD=4GK8_I7QD\4.!_%GP8\<LFR&.+HXK@FC#ZY+$X&M0IT\13Q5'E]E6
MG&,)U+PE)P7ON+4DK790\:Z9#\</^"*'A[5`5GU+P#\,]"UJT?!D^S-\+?$,
M>F/&63C,.@Z<Z-C(PI*YKFO^"$^NP:Q\+/VB_AK?HL]AI_BOPGK\UDZD+]C\
M<>&]6T>X!''R2'PC<KZC9D@`H6_+_P``?\%$_BI\+_V6]9_9:L?AEX.U_P`$
MWOACQQX=O/$>H?\`"31ZR;3Q4FK+J,D48E>":6$W]ZYP&6/[+E\')'W7_P`$
M$Y-07QM^TO&SJVGVWA?X=1WLO!C:^M]:\66UB&D')46UO?,A.-RW)(YW8_7>
M,>!,ZX7\(O&["YBZ5#!X?B.ECLJY*D9SC&KC5!Q?*_<M&#M%*,KN[NM'^&\`
M>(?#G&?CO]'C'Y-.M4Q_^K$\ISF56G*G&M4_L^I*D_>5ZD&XSE4FW*-M%9W9
M^)_B--:^`OQI\00>';LV^N_!KXGZO::)J`4%XM3\`>++J"TO,#[JF[TZ-\X_
MY:?4C],/^"NGQ3T7XQZQ^RC\0=%55B\4_`63Q'+8":.6ZTZ^UGQ%-YNG3*C?
MO)(KZPU*!G0&,M8L0VUD+?F3\:O$5GXQ^-7Q>\763BXT_P`5_$[XC:[9RI@I
M-IVM^+]7OK)B5)'S64\!(4GES@D<GE_$WC;Q1XIM?".E:_J]QJ%AX'T$^&?"
MUO/M*:5H)U.]UC[#"?+#%/[0U+4'RS$CS\`XZ?TS4X0J9QFGA;QI)1CCN%Z$
MX5V[>TJ+&8:'/36CYHTJEG33^%.5[MG\71X[AD?#WB[X?TI2EE?%&-A5PZC?
MV:JX/'>TG-=/?HTXTVUO"WVM3^KG_@EC-#\6?^">,O@&_?SH[>Y^+7PYN3(N
MY8]-UU[J]MXL8Y466LQ-QG[N,YR*_(7_`((X>.]0\"_MD6'A6]N);!?'/@KQ
M?X,U.SD<O"-0TS[)XAC00XP)4U+1YERI)/D8R5(-?J;_`,$,;J:7]E7X@VY8
M[+7XS>)4B5L$I&/"7@>8KTX_X^Y,_6OQ;_97G.B?\%._!D6DD/;P?M)_$+2X
M%C.(FL#KWC;3D\H*>8?L$BG!'13P>*_F3*LMP]?-_I9\.\G^R5HK%)/I5;Q&
M(33:LK591MI>T5KH?V1G>>5<#PY]!OC9W^O86I'+Y)-^]0<L/@^_-)NFG=-\
MOO2]VS/T'_X+A_L[V^FZK\/_`-I3PYI\%M!KLJ?#?XA",F&:]U6&(WOA#6AM
MZS_V98ZM82.1C-O8\A`S#[,_X(R_':^^)_[,!^'VJ3B?6?@IK2>"X7$>UG\+
MW-E'JGA:0.0-UO':O>6D)ZB/2U#*"*ZW_@L=!:G]B'Q9+.(O,LO%WP^FTYIV
MS,ES_;L$+O$3R7_L][L'V)[9K\Y?^""^JZC!\4?VAO#]L[2Z/=^!/!VIWG4P
M1:CH'BK5=.TN2,]!--8>(-9W<`LMM%UVD#XR,9\7_1.Q\\TJ.KB^!\QA0P%2
M6]*A[2C%4X-WTBL742](Q=U3BE^E8I1X"^G1@*&2+V&#\1LK6(Q].'NQG5E1
MQ-1RE"-H\SE@J,G*2;;<Y7YJC9_3HG4!>A(8CI@$#C\SC\:L55CXF(`X*G/'
MILP:M5_(2=W+NG9OO9;G^@D8J,4HJRU_-E*\61TD5%<GR7*;`,E]K+M!R,/\
MX*\CE>H[_P`W7Q9_X)__`/!1/0OC?\8?B1\#/B+9:/H_Q%^(GBCQE96?A3XF
MZWX7\RPU35;F72;36]!GM[:S_M*/26M8I9PUXQ=&*OL(5?Z1[@-O!`!`7))7
MW.26)P``,\U3FF*X`$C`X/RR1H"".,;<Y&,=Z^UX*XZS?@''8S'Y9A\'BUCZ
M7LITL=A*>,HN-U+G5.>BFK+6_3;5GYAXG>%G#WBI@<LP.?8_,,O635_K%&IE
MN)KX>O&IR\OO2HQNU;7E;M>SWL?RWZ/_`,$A?VT/C=X\L-?_`&BOB3IFFVSM
M!:ZSXGUCQ=J'Q!\71:1$Y$EEX=B$:00SF$L(BXM[=&;>8B5"G]RM=_8K^%NJ
M_LJS_LD65KJ6F^!$\)1Z%IVL12P/K6EZO:S#4+/Q7YP58[K6QK<4%Y+A8TD=
M"A`W9'V4K)@D(H..-GSMGCIM!/7KQ[TD4D@9]V0-A.27(7MR&Q^@)KV.+/&?
MCGC"MD\\9F%'#X;AZ<:V%HX*-.A2H5(6<:D:44[RC;9NR6B2NSYW@7Z/?AGP
M-1S]87+\1G6.XKH3P^88G-<14Q.*Q5*HFIQE*H[KF<I.T%%7?9)'\Q7@G_@G
M/_P4S_9UUG7M"^`7Q6T#2O"NN7@:XU;0?&`T31]0,>(;?4[WPKJ=E<M9WR6L
M<2OY)>8")4CF,:HJ3_&#_@C#^T?XGM?"WB73?B7X>^(?Q-\11ZUK'Q?\2>+M
M;UF.VNM?FEAM]%L_#\DUI)<3P1Z6;F.:YG(<;MD:^6J@?TT"Y*.@;))(&9BL
M;98Y41QR,IZG`XP2<5JPN)(D=2K*PRK*596&3A@RD@@C'3UKZI?2-\0UC:.:
MX..78',*RC*MC,/EU&C7QBBE&*Q59IUJFFK2<(NR=M$?$2^B%X3XO+*N39C6
MS?,<K@H_5,)B<WKUZ66N-[O"TK^SHRFFTU*,K1;22>I^;/[8O[+/Q4^/W[%_
MA[X&^%Y/#T/Q"M(/AF-4GU:[DM]$2\\-V5G#XCGMKF&W>297ECN3!E`2)>0.
ME-_X)E?LK?%+]DSX+>+?`?Q3DT&XU[7?B3J?BVUD\.7UQ?V9TZXT#PUID8N)
M;J"-UN3-I<N``5`CSGD5^EM%?GM7C[B.KP?C>!WB8+(<?C5F%2/)[[Q":=U-
MO1-*S5KVUO?4_6Z?A)PC2X_R_P`28T*JXERS+?[*I24TJ2PJA[./[M1LIJ.E
MXM)O5Q;U/PS_`."F7_!/GX[_`+6/Q>\$>./A==^"(-)\._#>V\*WD7BG5[[3
M[Q=2@U[Q!JK-!#:6D@FL)%U2P#Y()-FPQ@#/Z$']FGP_XQ_9(\'_`+-WQ<BM
M+K3=.^$'@?P/X@N].N#$=,UGPMX9TO3UU_0[]@#!/:ZQIJW%M(0NWR4)"GI]
M9W3%IE@!4@INVNC,IYZY4\=NU>8_&'PWX@\8?"GXA>$?"UQ:V>O^*/!7BKP_
MHU[?3S6=A8ZMK&BWNGZ;=7,L$3RP0Q7L\4C,D;N%0E58X!VQWB+Q)G&7<&<.
MXK-*6#P/!<V\!4I-4J]'FJ>TYI3A:4K3?,FW?HKG'2\*^#LESSQ'XVP^5U,[
MS/Q`H1I9GAJSEBZ6)5)-1H0PTX.$(2B^5Q5[[WN?SEK_`,$=OVN/AAXZN=<^
M"7QN\+66E^7/I^E^-8?%'B3P%XL_L"Y<-]BUZ'PY8*L>]]IEBMKPVY?:47<H
MQ\1?M]_LUV7[,GB;X=>"M4^(MW\5OC%XJ\-:QXW^,/B6ZN+V:$ZE>ZC8V?AZ
MTA.I7$D\2(Z:U*);MS/<+>F5B@1E'W/;?L\_\%G?A'8CPQX,\>>)=?T94\BR
MN[/XJ>&/$D:(T9"FTNO&5K]LCC7[P+/(V%VX`.X:'P1_X)%?M#?%OXJ6WQ,_
M:_\`$UBNCS:FNJ>)K"3Q%_PEWC'Q?]D,#6&C7MU!$;:STMRUX)V$Z/;)B"VB
MD25WC_M+A[Q(Q/#^+PW%7&GB[P]Q'E658:M&C1RVC1CFN+K2I>SHT\945)5Z
MJH7YH1NU=<TGI<_SLXD\*L'Q9EKX-\//`KB;A;/,UQM"5>MF^(KPR_*J-.O&
MK5KX6C.;H/VK7+/D5UI9+9_I9\/_`-F72/VD_P#@FC\&_@KXNN+[19-;^$'@
M?5])UBWCE@O]"UM+&+7?#NJFTE*.P5+Q?,MY-A>.X,<BJ=P'YB_#O_@GI_P5
M`^`=QK'A#X+?%+0O#7A#6-3N)KO4-"\;-IFD3M,[*FK2Z!J-E<2VVHFW6'S)
M+<12JRE$D:-5-?TX:=8V^F6%OIUE!#:6EA#%;6=K;HL=O!:V\:06\$,:*`D:
MPQQ@*!A<8'`%/ENXX-WF.J9`(#*<G*ECL*@[C\IX'.2!CD5_)61^,O%61RSZ
MCEE#"9EE'$&/KXYX/,,+#&X:GB*DG-UE1F^7FO;5WUMTN?W5Q)]'S@?B>GPI
MB,YQF-R3/N%<MPN70S#+<;4R^O/#T(1IPHSK4[.48R<K1?N/G=XMJ+C_`#%_
M%K_@C!^T9JE[X7USPC\0_#GC;QOJNERZW\4/%_C'6M9MGO/B+=7U_=RW>B^=
M#/<W-E'%+IB>=<R^9<-IZO*H(X_5W_@H[^RK\4OVK_@'HWPY^&\^@6?B.T\=
M>'_$UV?$%Y-IUE_9NEZ/K]E-;"ZM8I&:[$^KC9A<'<6SBOT=M[CS%0F-U+2;
M0#V.W);)^\N2`",C/0XJ]6&-\8^.<WQ7".99AC,-B,;P8ZCP=6.#HT;^T<+J
M=.DHP<8>SC&G%17+&-DV=F5?1V\-<GRSCK),!AL72P''\:$,RIK'5I\ZHJ<H
M6J.3G*4O:RE.<Y3<F[MZ'P+_`,$\/V</B#^R[^SGI_PJ^(DFB2^(;;Q?XOUZ
M1M`NY]0TM;36M46[LA%-=01OY_E`%P5^^I.>17YU?$'_`()G?M$>)/V^)OVD
M]-N_`J^`#\:O!?CX0S:S?0ZZ^A:#=:%-J*M8K9F(7^VPN3!E_8X)`K^@^DP/
M0?E7/EOBMQ?E'$/%7%&`Q-*CFW&-+%4<9+V2Y7'%N]5TX<UHOI&_,DMTSTLV
M\"N!L[X3X(X,S*.+Q.2\`5<)5P">)G[3FP<5&DJLU\:<4E*RBWT:/C7]N?X&
M>-?VB?V:/B!\)?`,NFVWB;Q/_81L)=9E>UT\-I^NV&H7+W%Q`C-$_D6TC*0I
M.X@=Z^=O^"7W['7Q7_9!\!_%'P[\4IO#<]_XO\9Z;KFDKX9OKG4;865GH<&G
MW,E[+=P1/]HDN%)"X(PAZ<9_52BO)PO'6?X/@S-.`J%:$>'LXQ%/$UX<K]I*
MK3=)Q:J*2Y5>C!NROOKJ?08[POX6S#Q$RCQ/Q-*M/BC(\)4P>'DZTG1C2JQK
M1DW3=U*5JTTKOE6GNW1^#'[:_P#P2.UCXH?$;5?CA^SAXBTKPCXWUK4H=?UW
MPKK%Y?Z#8W'B-&EE;Q1X6\3:9!<RZ%K+7:P2S0F"-'8M+%=P2O(!\L^(?^">
MO_!4SXV65AX&^+_Q/L-3\'6EQ;,5\7_$R[U;0MUIM-K?7.GZ;I=U<7]U`5!A
M>6&5\_,[%^:_J,P#U`/X4M?=Y-](#Q!RC+<MRZ=3`YR\EI^RP6(Q^"HXK$X2
MG:RA0K37-%1LFF^9W2U>Q^6\1?1/\*.(<[S/.'#,\FIY[4=7,<%@<RQ&'P./
MFVG)XBA&33YM;J#@M7Y6^'_V)OV*/!7[&7@*\\.>'[R;Q'XK\3W=IJ7CGQG<
MVT=G=:[J-K"8H(H+6-B-/T:!'=8+=2P4'.>M?<%%%?DV=9UFG$.9XS.,YQDL
M?F6/FYU:L[<TI/1:*R222C%))))):(_>>&>&<DX.R++N&N&\!#*\CRFG[+#X
M>%^6G"[=N:3<I-MMN4Y2DV]6%%%%>6>\%%%%`'\\?_!9;]J/XW_!WQ7\,?AA
M\+_%VK_#[PYXG\)7?BC6_$'A_P`NQU?6;^+6_P"R8M(&MB,RP6UM`%F>&`Q[
MFNHVF,B@+7*?\$BOVF_BK^T+XF^)?[./QQU2X^+_`(&G^']WXI6Y\;'_`(2"
M^LX(-7T/0+GP[JL]^K->Z5=1:P\VVZ:9T>W40M''E3^C/_!1_P#8S/[7_P`'
M88_#4%E'\4_A]+=ZY\/[J[F-M#JAU"W@.N>$;B[4?Z%;7\=A8F*<AECN(8&;
M$8DW?&__``2<^.'P0\':?JW[.?B;P%IWP6_:5TN^DT?Q1'JUC'I.I_$632"J
M6[?:[WYXO$D<AD272U<K*D27MJ'A8E/ZQR7-^$<7]'+&99E7"\,RXSR2JUB)
MX>E%8O!PC.,XYO.JH^U>'C&*IV@[1FU>T4VOX%SWAWC3+OI99;F'$G'&(RGP
M^XG<)X*GB,14E@L>IX6G1>1QH2DZ/MI3ESOGC>4(RLVVK_DK_P`%&_V<+#]C
M_P#:8CL/ALYT?PUKFFZ)\3OA_"9)"?#%S_:%Q#<:7:2S[B;*T\0Z--);(2WD
MVXBBW':Y?[[_`."W?Q/7Q)X'_9-T"WB:V7Q#H.O_`!3U*S?=]JT\76D>&8=$
MBGC$G&4U/7XV4KDO;*%90KJW"_\`!1JXTW]LC_@H-\(O@)\/;B/6V\.VNC_#
MWQ5>V#J\%A>W/B.Y\0^,T-^21.VG>'I]05U4XCG\R'[RX'-_MB6DO[57_!4G
MP1\#K&)+GPSX1U;P-\,[F"+$%M;>'_#XN/$OCM_EX+"WNM6B3`^]9VP_AK]<
MX>Q%?-,3X)9_Q;6FLVX+X;S3-,=5FW[2."H4_J^&J2;?-SXEJ4Y-ZN2DS\#X
MJP6'R3"?2'X8X)IP7#_'O%>3\/Y71HI*BLP=5XC&TZ<8^ZHTFX17+[J222W/
MW9_86^&-G\._V1O@)I5[I-KI>J2_#K1=?UB*6QMX;G[3KT4^OR07[-"'-U&=
M7ABEWDG-N1@$'/\`.I_P3QNA\6O^"F-MXWL#(MIKGC+XT_$9;F,;?)TO6O\`
MA(=4L`P96$:B'7[*-`1A6@5>1D-_43^T_P"-;?X5_LY?&?QHD@L9/"OPT\5W
MFFR1@HL6H_V5=6VC0P[!A)'U2>R1,=&D6OY[?^"%GPOEU7XV?%_XENF-,\!?
M#C2/"-J3@YU_QOJK7:>6?X1;Z)X2O?,Z9?5_3`K\9\.LZQ%7@#Z0/'^/FUBL
MXC0PJYI2DJ=7,*E><HI2;5W&M"-K=%;4_H/Q<X:PL/%+Z*_A5EF'IJCP^ZN8
M5)PIPA.M'*J-"%ZK@E)\_LJEVVTVW?N?/O\`P4F/_"1_\%+-:T_3$`O)?$/P
M;T)%CSD:@=-\-6J*`"<2+)>P?1D'&.*_9/\`X+4Z?:W7[&;WERJR3Z9\3_`U
MU9EL;EFF?4[!F'&=WV6:5,@])3G/%?CS>6+_`![_`."OTEHL;7-NW[32/<*C
M?(^F?#"[@FOMW/"F/PA`JX(X=S7ZE_\`!<WQC;Z-^S)\//"`GB_M'QK\4M,:
M*'/[RXTOPMX>UG5-2NT`X`CU"XT4#WN<U^A9OAI4N/?HK<,4'?'9;@,'B*JO
M]BM3IU&N]DJ3OY;K1GYAP_BZ>*\+_II\8U4G@\ZS/&X>G+3WI4ZM:,9=FW3Q
MM))K;E5N[^;_`/@C#:S:#\`OVTO'%Q&J6+:?I%F)FSY+R>%?!WC35KLDYS\J
M:Y:[^1\KC'/)^6?^")_A5];_`&PI-1A):/PA\+?&.L2LZ,8UCO'T'P[8SEP,
M?/<:M-A",L$R/NG/VO\`LS6+?L^_\$?/C+X]NHDM-0^*FE_$C4;=WE"S1OXJ
M>#X::%'&0?GF2"TFEXZ>3[DU<_X(5_#J#0/AQ\;?C=J=O';KXAUK1_!&FW[B
M,);:1X,TVXUS6+BVD;F*UDO=:M$F'1AH41P2G+XKX@H?V!])WB"FW*CG>:8'
M(L/+K4K4J2P>(:[\RC.H[:W>G87`_"M1<4_0UX8Q,4ZO#V38[B#%II-4Z.(J
MK&45).Z6LH15]M[Z7/C/]INX@\9?\%?M!L-*MM\EA\<?@+I'EQERS_V$_A:^
MU`LP8NK(+'YMK*=PD#Y!`7[%_P""]/C4V?@7]GKX7QNI.M^)_%GC^[;C"IX7
MTRP\.VQE",N'DN/&]VX(')M7/8@_#O[$5U#^TI_P5#'Q2$4KZ3??$'XB?%R(
MSY,MMHEK%K$GA4."3ME2WU70_97@&.F*]?\`^"O=TOQ<_;D^$'P8LI9/M=KX
M8\`>"98D8X@U/XF>,+UIID[>8MM/I*Y'50,_=KVX9;3P_B]X+9#BX)2\/N%8
MXO$K2T53PDZM2]GNHI._=*W4^9AFU;&>!GCYQ'@H*>)\3^-J.7X*FDE&K3KU
M\/"#4;6:<5)VMW[GV9XNAL/@/_P1BTZWNHHK/4O%WPBT&RC41)YW]H?%G5O[
M2NF1'4>7J`TC7+SDJ51X5)0A2#\Y_P#!*:*7X3_L:?MH_M`SM]BW65_INF3R
M-(JRR_#_`,!ZIJ%O/`68%U_M?QFL$9#Y,MM@G<"3ZE_P7&^(VG>$?@]\#/@7
MH5O%:1>(?$5WXGN+*#$4%GX;^'VCP:'IU@EO'@)#)J7B6V\I>@&B/@``5SWB
M>Q/P._X(B:3IT<7V+4/BA8>'+V^9ODE<?$'QC%KTCEE/S#_A'[=.3U4[>E?"
M9;]:S3POR[V_.\9XS\:K$24Y2;^KQQ$>;=RM&-2$TMM->MS]$SF&"R;QFS5X
M2$%@/H_>',J<:E.$8.IC9X"<%-\J2=1K$25W?=Z)H_$?X`?`N;XO^'OCAXBN
M(=0M]"^"_P`'M7^)5Y/;,D<1U&UO=-L=*TRYFE@<%9TN+^38I21DTYBL@P<X
MWPT^#6J>/OAY\;?B7*)[3P_\&/"GA[5;^\C$8AFU[Q/XBL=$T+097GSY\LUF
MNO7>$V,D>E*K-F0;OUP_9$\!IX,_X)3?MJ_$ZYMFCU#XF1:QX>MY%.9Y=!\)
M1V?AJS7`_@76M2\3!1Q]RJ&L_">#X#?\$<M9UG4H3!XH_:!\<>"/&FHF:)$F
M72+_`%U+KPQI;D#+NOA[28[EP3C&IMM`!(K^@,7XK>SSS.,IRVLY^RXJR;(L
MN6Z=*CAJ,LVDU;2W,U=WULTUT_F;!>"F%?#/#.?YG35*E2X-S7B?,?*6*Q&)
MPN6PNW?WI2P;WOHWKK?[B_X(L2V_A/\`8M^('BC4I/)L%^)WC_6[FX<84Z?H
MGAGPM9WURA.,HO\`9;9//(/;`'X[_P#!+[0=0^)_[=_@'Q-<0$RZ-JGC3XBZ
ML45C&LSZ=KK.RJY=E@-]JUF%RQ;,Q!D)(-?JE\"=<A^`W_!&'Q/XOGEBM+WQ
M/X5^)<6F&8?*VI_$+Q3?>$]+8A>6BC6>*:0#DQ61YXKY4_X)+'P+^SS\-?V@
MOVTOBI,VGZ!HMK8?"WPG&6#7NIWS-%K^O:/I%N?^/G7+W5)?!5C9(""SV=PG
M(<D?CE''RPV$^DSQ%AZ,L1BN)LW629?""YIUZSE*@H1BM6^7$*22W<5V9^[X
MO`4,9C/H?<'XW$4\'@N%,B7$V8U*K2I8?#QY:SJ3;:2]ZBTWJES72V/I3_@N
M;\<;'3?`WPX^`%A<QRZQXEUT?$CQ!(CIY>F>&O#UGJ>F:9!>1;B0;W6[X2P@
MCF'1)\89T<=-_P`$,_A#J7A/X2?$SXMZE9/;-\4?$EAI.A"ZCC29M!\%I=VS
M3I*(T+QRZUJ6IQ,0-DC:(TB*JNHK\>?#/A[XN?\`!3G]K[5;Q(Y;,^,M3@O]
M>U.#S=0TCX9_#33)Q!9"*67Y)O(TM8X;)3B*ZU&YBCFPMV"?[*OAA\./"?PF
M\`>$?ASX*TT:7X7\':%8Z%HEFSO/,EI:0JGFWEQ(`UU>.X=Y97^=Y979CN9J
M^2\5JN#\+?!_A_P6HXGVO%>;\N.SN,9)K#U).-2*C+JI<M*,+;JC4G+2HC]&
M\%,NQ_C1X_<5>/\`5PU3!<$</-Y?D/MXVJXE0C*DYQ6RIJ-2O*:UY77IP3O3
M;.]0`$$G+'"G&2,X!.#GU7]:L5"BJ,9))SGVS^7^<U-7\A1O>6MX.UGWT5V_
MG<_O^#DXISCRR>Z72^OY%.Y3<'.X99450V"N2[#[I&"3GOZ#TK^4O]H[]OK]
MN+1_VM?BG\%/A1\2KTQ6'Q(F\)>!O#5IX0\$ZA<2M<2P6FGZ;#=:AHHD:4W,
MG+22N<-@$<`?U9W:@JS9(P`QP#G"'/''/:OXK/CGXTTCX=?\%./&/Q$U]+W_
M`(1_P+^TG9>)=7.GVHO;N33-%UG2=5OXK6S_`.6TR1`\CG$A':OZ:^C-D.59
MYGG&L<?D=#B/$9?E%3$8;#8FFJD/;J6DDGI=VMV/XO\`IG<39YPYD/AS_9/$
M^,X6PV;9W##8^O@Z]2C.&!E!.<VZ<HMVWTU/H[QE^V#_`,%;/@-!:>,?BO;>
M+M%\."XMK1IO%GPM\$3>';B660>79W%]HFDL+>YDC^4(US&Q8_(^[`/[5_\`
M!.S]MX?MH?#;Q-?:SH>G>&_B5\.[S3M,\:6&CF=]%N[;6H]3;1/$.CI>L9K2
MQNVT?45:UDDF:WEL&5YFW+7YF?MK_P#!5+X+_'GX#>*O@A\+/!_C/7_$'Q+@
MT_1EU#Q%HUGI6GZ/`FIVES)?6MDU[<75YJIFMUBMBBK&5G.V8.H#_3O_``1K
M_9=^(GP+\!?$KXA?%'2KCPUKOQ>F\(3:+X5OMIU32=!\,V>MS+>ZG`29+">Z
MU#Q'=A(9OWBQZ>A(Y-?3>(V393B_"2MQ!QAP!@?#GC>GF%.CEM+!T?8RQ^%3
M@ZDYQ]L[<L7)ZPNK+0^%\(^),^P?CMEG"?`/BSFGC#X=XG+<77S2IC'5JTLO
MQ,8U5&*JU(7CR2C1Y6I6;J.CJXW/-/&W[&G[;>N?MTGXR:!XEOU^"(^.7A'Q
M:VFQ_%K6;6(^$=,U/1I];M6\+P7GDR1RVMK=?Z/LVL#M;J17[[6,C)8VVX2`
MI!$'66.1)58*,JZ2`-N!!'(!]?6OY>/BG^U?^T7I7_!3*3X2Z=\7_&-K\/!^
MT-X"\-+X,@OG?1)M`U34_"T5_I4T3H0EJ]OJ%RCKUQ,>>1C]>O\`@H3^VO%^
MQM\+[/4='ALM;^)OC>ZN]-\!^&[QI#:H+2&&;4/$NJ+:MO31K&.94=`-T]Q?
MVT2E>37P7'_"/B!G>+\),CQ&'P&-Q_$F4TGEU/`PY)4:+DDHX^R2E6L^>4T_
MAB[O0_3?"+C[PPX:R[QRXFR_%YI0R_AO.:SS:KF57VL:^)BI1MER<KPIW3C&
MG=;I^:_0MKZ0<JA)VE_+\MP2HX)5F*]._IBIX[DRX*E<$!LX*D#CC!)_G7\H
MGPE\'_\`!4S]M+0+KXO:-\:_$7AWP[J5_?+HMWJ7C>7X=:/JSVKB.4^%-&T.
MS(GT99L*DXS`Q!P20:Z+X$_\%!?VJ/V0OCL_P6_:[OM7\2^%+75K31O$TGB=
M[.ZUWPA9:@T45EXLT?Q2L*/KWAPLHE;S_E$)?GS%6C$?1[SEQS7!9+QME'$7
M%.04W4QV48:<OK5%05YQBY)*<X[-7^+1V=D:Y=]+7(Y8G(<9Q)X>YWP5P9Q-
M65+`9YF$8_4\3*5E!)1NXQG\46^EWJC]E/\`@HG^V[:_L8_"W2]9TC3].U[X
MD>.+R]T?P+HFI&0V"/86;7FJ>(-6@AECDN=,LU-HGDI+$]Q<:E!&KJ`X/X;_
M``T^*W_!7+]JZ+6/B%\+?$?CF^\-QZA+:)?:'=>"_!7ABVU"VO%2?3=/74K>
M'[;+%;MLD$:S>0R9E>0L<_6W_!<7X8>*O%?ASX&_''P_!+K/@KP;#XB\.^*[
MNQB^T_V5%XGDT#5/#NOI&AV-I=Q-IUS:M(FX&XU"PP1M-><_\$[_`/@J?\(O
M@Y\(_!_P'^-.BZOX63P7)<6>C>.-'TZYUS19]-O;JYNA+K]O;;KBROXKN[N!
M-)"LY92I-OU8_IO`/#M')?!##<9<$\"X+CKC3%YA.GCUBL/''5<)"$IQ5)89
MJ\;QC!.*O*2DZ]^6*BOQ_P`5>*ZW$_TB\9P+XA^)&9^&'ASEN`PN(RJ>!Q%3
M`4<?B:L:$KU,?3:4.?VE5MRYE^[C17L7+F?WM_P38U[]N?4-9^,'AG]L:+Q7
M#;^%[;P5'X,'BK0=&MYK^[U4^(VUF6Q\7:1;>1XDLX(-,TS")<3/$U\3*Q#Q
MA?UA`*3`HI)"LH8N"#DY"XY(("G`X&"?08\\^'7Q0^'GQ4\*67C#X;>+]!\7
M>&M0B=[/6O#UY;7EC'M"EXYGC;%O<QH06@D"S!4^[@\_A_\`\%1/^"D'Q#^%
M7C>;]GCX`:D=#\4Z59V$WQ`\;VMN+S6;2_UC,VF^$_#D<UNT5I?M:/";FZ7=
M,J:C'Y($B;3^"X'AKB'Q>\0<5@<GX=PG#N:8R#KU\+3H^PPN"AAH)8BK*G%<
M\4WK9*4KNRM&[7].XGB[A/P!\)<%FN=<68[C#+,*_887%8BLL3C\?/$MSH48
M5E)TYM+2,JDU%)7;O:_]`*W6`W?;*$!VE<9ZY8MAFW`\9'TZ$_FM_P`%-/@-
M\?\`X_?"WX?^'/V?=7N])\4Z-\1%U?7KFT\7:AX)23P^?"_B>Q>$:A:2JTR_
M;;NR(3<1N&2.@K\IO"'[*7_!77Q=X2L?B5:_&'Q7I.H:K8#7-,\.>*_BEK-G
MXD4RV[W-I'J.AQPBVTN:4W$1-HXWP[%CE(D#`?<?_!6;XL_&+]GS]FWX$W?P
MZ^(_B3P[XIE\?Z;X8\0^*M-N`FJ^(+>T\!^)9+I]3EC3]_YVH:;;W+XX,B`C
MCK];DOA[4X9\1N!\OX3XYR7BW/\`$UY4^:E#$2PF&JJG+FAB8U8*,TK--1YK
MN_F?#\2>*=+C7PF\1,PXV\.,_P"">$\)@,-6C*K.A#%XBE4E!\V%E1DYP;;3
MO*RMZGW/^PQ\./B9\(?V;/`G@?XO:E)J?Q!T7^V&\07$NNR^)I))-0UN]OK-
MY-:GF=[K%E-`#EL@D#C`K[`-T-VT.A/`*C@].<$\$YQQG\:_.7]A?XWZK=_L
M'>&?C;\:/%E[KLFB:#X_\2>*/%>LR^?=OI?AC5_$$DMU<W$QP%ATJP5$+$(`
MBAB%W&OQOT[]H']O/_@I+\9/%^A_`3Q=JOPL\!>&DFO#8Z;K,OAC1_"VA3W-
M[:^''\8:]I:27.I>)-1%I?JMO'B(G3)YK;,43&O(P_A9G_%G%G'E7,LZR_A[
M+^&<;BEFF95>:&6T&L34BHT(QUO-V5.*3]VRMJD_:J>-G#'A_P`"^$^#R'A_
M->+<WXXP.$CDV54YT99EB*?U>$I5\3.K-62][GF[IN+VU/ZKEN,YX7CKAE8@
M<??"GY3R>.>.>]+YS#);'3("AF./7@=/QK^4;Q3\;/\`@H)_P3>^+'@2W^,G
MCZX^*/@OQ*6G33]1\13^*O#OB72+&>SM_$6FZ7J6I0+>Z/KMLUYI;*Z)*8S-
M&'5DOL+^QG[</Q[UI?V!==^/7P4\5ZIX=GUW0?`?B/PKXBL";+4[73?$FLZ&
M7B;J;6X^S74\$T9YC;?&V&!KASKP?SO*\RX,P^"S?!YYD?'V)6#R[-<.Y/"O
M$N48NG5NDXM74FM[7ZW2]?ASZ0V0YUE/'V(S#A_&Y!Q%X;T)8K,LHQ'(\8L-
M&/,ZE)P;A+6ZNFUMW/TI:X9`'+1A`N69]T2@@@$EF!P.O;K@4U+EV.-HS@MC
MU7=\K``\J0>OM[U_(Y^SC^TU_P`%%/VH=,O/V?OA-X_US4-?FU6]\4^*OBAK
M6K_8=8T/P_+;:9IMAH$^L3V<J>%[5M1M-0FC$4,MW//<2VN$2%WKEO'_`,</
M^"@?[`GQJT32OB5\5/$6OW36=GXFBTC6?%4WCCP5XVT%YI;6]MK:747C-I<(
M8&5WCB1HI760$JK!OM5]&CB26:YCPW_KID\.+,)3EB:66N<_;U\+"-W.%E92
M>K2=WRJ[BMC\Y?TQ^'O[&R?BS_B'F>1X)S"K#"U\V;PWU;!8B<U#V6(49RDY
MPOS2<>B>CU/[$A-G<,'*@$X!X!QD'/7O^=0-=2*'^0,59E488D[0IQ@@;CSV
MSUKY-\:?M6>"O!W[+T?[4U_)>#PE=^`]'\<:5I0*-J%[-XBTVVOM%\/NH!)O
M7NKB.UD9,JN99\$(*_G!\(?'C_@HO_P4)^*OB&S^&/CGQ!X1TO3U;4;K3/"O
MB6;P?X%\":;<3RMI^E:EXDMK;.I7FQ'C@D=OM-\8'EVI%MQ\)P-X1YYQ=A<[
MS;'9AA^&.'>':CI8O,L;[7ZK2J\T8>S:I1E)RO*[72V[;2?Z=XD?2"X:X#Q7
M#F1Y;E6+XUXMXJA1K8+*LO\`9?6ZE"I:5.M)U)**IXB',Z=M6HMV2/Z\(KMW
M5"RJ"?O\D%3AB!M&><#N13Y+K;N`*@H<$G`!^A+`=?\`/:OR9_8%^!W[9/P2
M\6_%&\_:D^+%UXT\)CPCID?A-9_'L_BW3[?5%NKV]UW4B;ZP@N+!XK&VM%\R
M0$>7<MMSV_-+XC_MD_M?_M\?M%ZE\(?V3O$]]X,^'-I)K/\`8-SHM\_A>XO?
M#NCW/V74?B#XIUZ6!KB/2KDW>D&UMEC1;07<(+O+>QXWRSP@QF><09[EV2<6
M9=C^'>&J,<1CL[3JQP%*A+55(^TBIN5[QY;:\K['+GOC_AN&N%.'<VXAX&S3
M+>+N,,56PF7<.OV4LQK8BG4Y>1.G)P47%JS>MW:VNG]2$=S(Q8.@X(4$!R0<
M9^9=N%&".=V,$58:4J"3@!0"20>0<=,=\5_*#\6-7_X*7?\`!/+5O!GC[QG\
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MW)"X.XC<`&Z].<=*_DF_9VTS_@I)^WPWC+QSX/\`VB]6T73]`UB#3M2GO_&&
MJ^#M.;5+Y4U"2STKP]X4L]D=K#;SQ(F"8.!AB1Q^Z?\`P3\^%?[4_P`*?#/C
MW1OVHOB+)\0-4N==TUO!-U_PDLGB.&+0;;28([V6.:[LXKB%WU"3<XD+`EP1
M[WQ]X48?@'#XJGC^.LLS#B++:JHXC*L.L5]:HR?+=SE4IQIM*[?31:=@\+_'
M;&^*..RV>6^&><93POFL<54H9OB985X2K"E+ECRJ$W-7=TM+IZ:ZL_0!U9T+
M+\Q:/8`<XSD`@EJ_+C]O/_@F]X2_:EL9OB)X*:T\#_'K2(K>32_$D8>UT_Q7
M'8-OM](\3_9&5S)A46VOU/VBUQM4F)F2OU0\ML*,KQ]X8.">>U-,).`-H`8%
ML[CD`'`_[ZP?PK\XX;XESKA'.,)GF0XR>`S'#SC*7+%3I54G'FIU82TG3E9<
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M%?X:?\$MOC%^R?\`M1^!/C#\`O'&@>,/`FGZV+7Q#H7C6[DTCQ1'X3UL&S\1
MVPN;'2C:ZS/#IL<#VTOR3O./WJ!?F;^F\)XN9'QI#Q/S'/<2N'N(^)N'*&6T
M*4G4J8>=:BY5)K"U;/V-.;5.U&?+%2E)J4C^+,R\!^*/#BMX,93D&73XTX1X
M4XMQ>;8F=-4J6)HX;$5*,:*QL'**Q=6FG*:Q--1M"FZ;IWFF?5/_``5[\42>
M&?V*/'UM92F&3Q3K_@KP\0A.#$^OPW<O(_A=+.)?;;G@"O$O^",GA>U\`?L<
M>._B?=VX5_%GC?Q9XAN)`A69]&\%:);Z):VN6ZH)M+U>1>.NH'`.*\*_X+6?
MM.:3>>&;']EM/!OC&SUT>)/"_C*7QAJ5D-/\(:C906MXJZ=HM\LC2:EJ"WEQ
M`9%,:)$%.\@XS[=_P3!\?:;XL_X)S^._!VER*?$WP^L_BGH.L6"N(YH)=>TO
M5_$NA7&R0@^1/;:H468X4O;2+N/EFN6ED>:Y;]&?#*>$FL-Q#Q+@JF(E%J?-
M0DIT:-27))\D9U8Q5IV<6DVDK2._$<0Y3G'TQ,RJPQBGC.&>$<11HIQG!^WI
MP]O6II3C&[I4YRO->Y*TE&3::/S._P""/UC<_$+]NN]\;:Y_IVLV?@_XC>/=
M4EE"D?VGX@O;/3=2N`?XMU[XJE'&2?-SR`2/8_\`@N9XGOO%G[0GP/\`A?I`
M^UW/AOP+<WEE:*RL'UCXB^*5L3%(&(R[1>$-*QR!B9,D5Y]_P0PD%M^U/X]$
MN"J_L_>(=[R'$H>'QS\.%<E6.Y2S&0\X.%.1GBNL_:_L#XT_X+&?#S0-00RV
M5MXU^`]EY$[#RGM+&+1->N8D5R0T+)#-(0!R)).YK]BS6I1H?24S'-)\M2CP
MAPM*O1BK-Q=+!3222V?[^:^5C^?LFA4J_0^RO*Z=XXCQ#XU^H5YM:-3QE--N
M7PNWL8+>WXGNO_!576=*_9W_`&)_V>OV3M*O/.UC4[;0AJ$D4!$<N@?##0+6
M36M8E16)CFO?%=SI$D:@%WWW@P,`-]N?#KP5_P`,R?\`!+'5]-N+(Z3K&F?L
M\^,_%FKVB*HFM/$/C+P[J.MS6DHC)!N8I=8B@;DKNBZG!-?DC_P46\2GXV_\
M%.O`'PJOC]I\.>&=<^#_`,.([,,1FWUW6].UKQ0P#':KR+K13)QN%L@;@`U^
MZW_!1*=M._8>_:&FC=(I!X)2PP&5?,CO=;T:PDMHNF<V\\JJ.I5@#SFOQSB/
M#U\#POX&\+8QREB./,T_M[%\UXRG+$XNC2H;V33A*3;OT3>EV?T!P=7PF:<:
M_23XPP25+">&F1T.&LM3=O9T\%@,3/&5(KXK5)TTTTK.SM?2_P"-G_!"+X<M
MJ/Q1^.'Q7N%!7PGX+T'P79!D5I+B[\9:O_;^JR^9G"SQV_@K34.3TU$8/#8P
M[JU;XQ?\%LWBF#7MEX2^**2A6*E!%\+_``9]KL223D"+5+2,^[2#;GG'U1_P
M0<CMH_@M\<+M6C>ZN/BKI%M.RX$BQ0^$;)K9)@V"$\V:?:/<GO7S9^PLW]N?
M\%>/CWJ-XFZ2R\3_`+0DB/+R\<MOXIU#0XA'G[K"TA?DD`IQGT_1N)<QJU/%
M#Z2N<5*BY\AX>6&H)--J&(CA8)JVR;C)I[;ZV/RGA?)Z'_$&_HE<-PC:GQ3Q
M;''XB33BF\'5Q$Y[VNTFM-9=$FUIS'_!;*]OO%_[6WPG\`Z9/(+ZV^&WAO2=
M-4<K#K'C/QCKD,%TH)Y=)K:R/IC';FOM?_@L=I&D_#+]AKX1?#7PW;K8>'M'
M\>_#KP'I5N`<6^A^$_"'B%=/A(`Y6+3]$A[<C@`GBOA;_@I+XBTFP_X*A?#O
M4/$5Q'#H?A;5?@$VL/,I,<&D1ZQI&KWTDA&0L2PWTS-G`'G`DXR:^]_^"Y=J
M^K?LK_#&ZLY8I0OQU\-30M$ZM'<1:GX)\=6<#6[J=L\8>;>2I*F,[P2,5YN!
M]LL9]$7*XQE#!5Z>*K<ZA)Q>(JU:2<;Q3?,FDTM%[UT[:GJYS*&*P?T[,W:=
M/-*6(P5%\UU_LD744+725I*[T=UHG;8]M_8[^`7A[XM?\$R?AE\)-?-Q::%\
M0_"4E]K9L&B666.]\;3:_>6^V1"&29M.BADR>8KN4=<9^3/^"Z/CS2O"_P`(
M/@9\#]*@@M!K'B;4_%DEK9QQP6NG>'?`&C+HVE6/V>-0L5L]SXB)A"C`&B.H
M`.T5]X?\$OOBMX(\=?L<_"71/#GB&PU+6_`F@?\`".>+=)ADVZAH.KVVI7DT
MEI>VC`,F89HG#*"A69#GYJ_$?]N2'XD_\%#OVQ-3\,_L\>$M:\=Z'\--,'PR
MM=>M[.XL_"=O>Z1JVIWGBC4]5\27JK8V4(U:^N8"IF^U/'9(P@*[2?DO#W`8
MBMX^\0XWB.O_`&;P]P;F.=9IBIXAJC1A4J^VIT74J5.6*=1PH\EV[I75E>_W
M/BQF>7X;Z,7"N6\)X)YMQ/XD9+D&1X:CA8NOB)T::HUJD84:2E.U/VE9ST7*
M[*33L>K?\%`?$\WPI_X)V?L2_`&.*:SUOQOX;\.>,M;LC_H[_P!G^'/#%OK6
MMVMZ&&Y;A_%7B[32,='M7/&TD?!_[.7[.W[4O[:^B^%/A+X7GO[7X+>`=5U&
M^77-6@?2_`'AV\UC4;K4-1UD16D,?_"7>*I?[5N4@7]].JPRB>:*!G63^F>S
M_88\&_&/P#\$3^U[I6@_%/XJ_"C0WTQM2T2^\0Z1X1N'N+J.40W.B66H6]OK
M3BSLM,222>$JYMR/)\L@'[?\*>"]`\%:/8>'?#&BZ/H&@:1`EII&CZ)I]MI6
MGV%FK&000V=E$D2*)6<C8BYW?-D\G+"^/N7<'<(8K(>&LBIYKQ?BLTQN.JYI
MB5&>'ISK5L0H5<''XN;V55<LI1A9;QW1T5_HI9UQ[QOA^)N,>(:F2<'X+*LH
MR[#95A7RXFI@L+A</[;!XN:]RG3^M4Y3J4(.<6F[2O8^>/V5OV3OAK^R;X!C
M\%?#O3)[B\OI8;OQ=XPU)8#KWB_58D<_;]3G2,&.W22XG^S6Z$10(=JC)9F^
ML85*11H2254+EOO-CC<W)RQZGW-(L(4``D\D\D_>^OI4B@A0#R1Z?7WK^8,R
MS',,YS/&9QFV,GF.8XZ<IU*U76J[V]V]O@2BK*^EDDK)6_MG(\DRKAS*\%DN
M1Y=3RG*,!3C3H86BE&C0C'2T%IK)^\WU=WNW=U%%%<AZY4N2!C/`P3^7KQ_G
M%?Q=?%;0=%\6_P#!5+7O"WB/3[75_#WB7]J31]$UK2K]7:#4-.U;Q'H>GW]I
M*J2)OA>W<G`+8VG(Q7]H=T0?EW#<5.U.`3@C)!8@=2,\C&:_E0_:*_8`_;FU
MG]KCXI?&WX5?"V]:UO/BC<>,_`GB6S\7^"]/N(_(GL+FQODM[_7!+')]HMGX
MDB7H"`0>?Z4^C1G&2Y7F_'5/-L_PW#U7,\HJ8?"XC$5H48QKRE>,>:35I+>]
MU;>Y_&'TS<ASO.LA\.,1D_"N-XKIY)G4,3BL-@\+6Q,W0C%*4W&E"5XOX;:W
MVM8_3#]KW_@FW^R$?@!\3O%/A?X>Z+\+?$W@GP5KWBG1?$GAN>ZTTVVH:)I-
MUJ-O87]G>7CPW=I<W$"Q&)E#LTR^6=X7=\1?\$1/V@/B/J7Q%\6?L]Z_K%[K
MG@&U^']WXT\+07UW?7K^%K[3-:T+29=.T@WS,]CHL]MJIE>'*;9A&/+!5@/)
M/&7[*7_!8+XUZ='X)^)EQXKO?"FH&`WVG>)OBMX.BT"1496=M1MM#U;S;N)6
M0,L;1SKO53M!&X?K7_P3G_X)_K^QWI?BCQ=XWUC3?$WQ>\;6B:=?W>CH[:3X
M7\-6MS+?)X?T6[DAC-V;FX2QGO9)`N9]-C$9,8S7U6?YGDW"G@_Q3PKQ=XEY
M?XC<1YYC*<LKI83$PQ\L%*,X-UO;UG.I!.*:]R<6WM'WFG^?\'95Q)QMX]<#
M<:<">$&8>#O"_#E.O_;5?&819<LQI3:Y:,</0I4E5E*5I)2B]FW9I)_AO\:#
MN_X*],_:3]J;X:NH'\(;7/!QQCMSD_0U]#_\%V;?5Q\>?@K(58:._P`)=433
M6D7RHFU6#Q;>G4_+D;`E9;66R\[!(A6Y@:78)HB_3?$[]B#]J;Q!_P`%'Y?C
MIHWPGOKSX7K\??!/C(^)QXC\'0Q-H&BW_A^ZOKU-/N/$"W3!8]+G7;Y.YB1@
M8SM_7?\`;R_8MT7]L[X3V_AU;^V\.^/_``E>7&K_``]\626\4Z65[=VIM=2T
MJ_=4=Y-#OECMA=QQ@EC86S[2T*U]%CO$O@[(>./`/.<5CX9EE&29&L%F/U::
MG4PM6I!QM+EO:=-R4I+LI==#X_)?!SCCBWPU^D_PU2R7$97G.<<33QV`6+HU
M*"QE*EB*U9>SC4C&4X5:;M&237-*)U'[!USX=O/V.?V<&T(P/9I\*/"ME<PP
MDRE-8M+)+?6FD"#*G^W5U$OD84W&2<5^`?\`P7%OM!N_VH_!=II$]J==TWX,
MZ;_PDWDRV\<\5Q<:]XJO-)WR;\@K8OO`(V[9-Q((JWX%^&__``5__8_TN_\`
MAK\)_"WBC5_!UQ/=7&GCP[9^"?B/X0BN[Y99[G4-`;6D>_T&%KR1IE@EE@A5
MPIY&0WH_[.O_``2\_:2^//QIM?C9^VA+<Z9I-UJ]OXD\2Z%K^L6.M>,?'4]L
MMH;'1-4BTF66STGPRWE31RPH87MX7:"%")&)Y>"<GX:\+N/\^\6,U\0<MS?A
MRFL56P6'P>(Y\RS!XIRY:%6E96<.;][S6U5[VO;UN/>(>,_&GPNX9\$\C\)L
MXR3BF+P.'QU?'X2='*\O6"5*$L12K27*XU/9I1<+VIRJ*SE:_P"YG[,.C+JO
M[)WP&\-^.=/6^;4/@A\/[#7M&UVRCFAO;>?PKIEO/I^J:=J$#*^^W9(YHIDR
M%!&`RMM^!/VHO^"/'P!^(>FZ_P"*_@\LGP>\?0VEY>:5I^GRL_@+4KRSM+AH
M;"^T6<D:5!.<)+-9,C+&G$8`Q7L/_!2OX??M<>+O"OPI'[(K:U;ZQX0\47NM
M^)4\->*M-\,:DUE#HMUI6BVD2:I?0PWUF\M_?EXRI^>W@R=J';^0GBNX_P""
MU/Q2T"X^&?BGPU\6KK1=6@;2=6B32?`'AE;BR-K);7-IJ7BS0IK$WME,'`D:
M.\#,`2)BQ(K\]\,\DXGQ&(7'7"GBKE'!7UW&598S!XG&PHUJ5&=64OWF$E[M
M=<M[<UGRM62OS'ZEXP\2\(X'!R\-.,?!K._$&64Y=0P^!S#"X*I6I8BM4P7L
M:TZ6*BN;#N$E%3<6US-M.5K'G?\`P1Q^+'C#PK^U?H/P^TS5=1;P;\4=)\16
M_B7P\LI?2GU#2=!GUC1-;6Q`'V36(7T^XMSQG[&4[`UP?QIGL-,_X*H:W=>.
M4QHT?[3'A2[ULWD3QP1^'1XATB>T>0NHQ;I8NLF022DBE<AUS^OG_!,G_@F=
MXJ_9T\4W'QM^-=UIJ_$$:+J.C^%?">B:DNHV/AU-;AMX-5UC4M2@MU6;7?LP
MO+2(P/)&EM>L=PD.T9G_``4P_P""8/BSX^^+4^.?P).E2^.[RVM[+QEX,N[N
M'1#XFDLXW2TUW2=:G(2+6C;0V%K(DSQ1B+38)(W\Q6!_8\3XJ>'$_''B25#,
M:.$RCB3(Z64U\X3<*$L;.'+4Q2DXKEBJ35!R:Y>:%[V9^#8?P1\6H?1RX3^L
M937S#.N#^)*F=X?)96J5_J$(4:,,.E&4K-RI2Q"PT')6FF]59?N+;75O(SM'
M-"0%#S`<8+IO1F?.%&W&"3C'2OPZ_P""\;[_`-GGX,R'&#\:86R""-H\">,S
MD'/(VX/TZ5\9^%?$'_!;3PMX<@^%FD>$OBB;+2XCI5CJFHZ-\.-7OK>SM@\0
MAM/&6ISO)*8TV"WN&G9"K@"-65G/V]_P4$_9W_:8_:)_8T_9=\$:%X,O_&OQ
MF\+W/@G6/BE8SZ]X:L+VVU>+X7ZOI'B34+R\U?68(;B8^)+[:XCD8L\^Y05R
M1^0\%<&8+PN\4>!,YS?C/)\TROZ_67M\+BZ=65/#QHU?9UL1RM^QISYDH\SE
M9V4FGO\`NWB-XD8[QF\$_$_A[(_#SB#*\WCEV&?L\=@JM-U\3]8P_ML/A%9N
MJZ:4I6BDW%-Q32;.`^'R:K_PXV\0_P!CF87,?@KQ5(\D+R)/%IEO\3O/U-O-
MCYAA33(;MI78B...)GD(16(_,_\`X)^^"/VX_%^B?$6']C[XCZ3X'L],U3PV
MWC?3KO6=)T>^NIKS3K]-"O6AU'1;AS:&UM+N-94>.)RF?+;`=?Z+?V&?@7XB
M\&_L2>$_@3\<O!#Z9J%QI/C7P_XP\)ZC/8:A')I'B/6]:6>TGGTN[EB>.?2]
M0.&20X$F>HQ7X[^(OV!OV\OV)_BQJWQ#_8]O;OQ]X?N7NK6TNM+NM$O]:O/#
M,MQ)=VVC>,O!VLW5I%KI@=I`7A=C)+Y4J>5M9#]YPAQSP_B/^(S\&TLURC"Y
MQG.?SS/*ZN:TJ=;*\<O;Q4J->;?*Z?)"-2'2\^97<6C\P\0/#+BF%'Z/?B%4
MR3/,7D?#O#M#*<VHY+.KA<ZR]QH.7MZ$8Q]KS\]25.5+EUY+.RDF3_&']@O_
M`(*F_M`:9I6A_&7QMX/\=Z9H>I3:MHT.L>+;"%-/NY[62TN[JWFTW0X)))3!
MY:?,QCPQ)'6OKK]HGX9>-/@Y_P`$?[GX7_$3^RQXK\(Z-X:T[61HUTE_ITH_
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MCGUBNM6U:0=L7V.H->%?\%[XXE^*/[.LX7$LO@;QZCL?[D.O^'D7..I+,/\`
MOD5]W?\`!(3]GCXR_LW?#+XKZ!\9O!4_@[5_$/CS2]6T>R?5]`U=KW38?"]A
M82W*OH6J7*H!<HXVL0WR$XV@D>-?\%@?V4/V@OVD/'GP1U;X,?#NZ\96/A?P
MKXTTW7)X];\-Z.MC>ZKKF@W=C"_]NZO;&7?!:SL"@8#RSZ''7D?%&00^E9G'
M$L\\P]+(*GUEPQDJL51E?`M0]]M*TII13VN<V=\&<23^@SDO#%'(<34XBC##
MJ6"]E)8F+_M&4I7I64DXTY<[NKI.YQO[6UO?W/\`P1F^`#Z>CO%!X<^!S:D5
M0D"U^QO"I=^B*9YHEYZM(HZL,][_`,$*)_#LGP)^,]G:RV;>*+?XMI>:O$F'
MNDTS4?!NB1Z*;F)?FA)%E?@*P#AHBK*#@'[R^&W[-H\;_L)>`?V;_B_HXTJX
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M`:<D7F&19F\*:E'$\,:_/*`Y3E`<EMHR2`?X[_V!/#/[5/BSX@^*M(_9,\9:
M3X)^($?@Y+OQ%->ZAIVEW>H>'AJNF&]M;.XO])N#/''JQL)C&,.5F$@W*&-?
MNU^P;J__``4@\;_&'Q!K/[8.A:]IGPMN/AIJVA:-I^NV'@+P_HEUXGO-9\/S
MVI/ASPP8KF:X&D6.MPM+<1*`-0`2+&XK\>_&[_@FY^U1^S7\;M4^-?[$-XVH
M:3)J&J:KHN@Z#JFGVGBSPQ:ZJTD^I^&CI^M^7:^(_#S7,J11PS&?;;VT*E!(
MH==?"C%9/X?T>//#7-^(,@Q>?YWAL!7PE>NZ6,R2KB82;JX;$U4[1C#XN6UN
M=MJ4M&X\<LOSCQ3J>&'BWE7"G$V%X:X>Q.8X;&X;#*IA.(*%&2BZ6/P=&2U5
M?F:4HR;Y5RNVJ(_BU^Q;_P`%:?CAX6;P;\6/B/X0\;^%%U*QU>32=5\7Z+%;
M'4--,S64I,/A^)_,0W$C8$@/R#`Y&?N+X`?L"^++G]@O7?V2/VA+FQT>^OO%
MFN:MH&I^&+\:\NAB75X==T/5TDN`BR/'J\5V#`7(\BY*Y&\*/C"Y^(O_``6T
M^+-O%X+C^'^J_#^.>'[)J?B>R\-^#_`%P+-BNXGQ!J.N3#2)0&D#2V*L[HJE
M($8L[?IW\1_`O[6GAK]A;PUX#^&.J76M_M,:%X?\$6M]KFGZ]8RW&HZM8:M9
M77BRY35/%-VBWZ267VU0TS*9&D&`H(4>1QOG?&N`PW#'#=?BCA'*G5SG#XFB
MLDE"$<%.$G_MTY07LZ=**=G92FUKRZ-'H>&O#OA]F.9<;\7X7@CCWB&6&R3%
M8;$U.)'72S.E42:RJC3E%5)U79R32]G&3^*^_P"&7CC]A_\`;Y_8.T_Q+\4?
MA?XXNG\(:.J7GB/Q#\+?$MQ"@TBT9=FN>)/!^L6C-?0P1,[2$QW7V1-S)A5:
M1?U>_P""4W[??C/]JM/&/PU^+BZ?<_$?P-HEAXFTWQ%I&G#3+?Q-X6O;N/3+
MR75-/@FDBM-8M-1FTY-ZE5NDOFE2-2DE?`7Q%\3_`/!:'XO>"-6^#?B?X1^(
MK;2?$]D=&\1ZEI?AGP%X?O-9TRXB,-[8:CXDBUG[*EA<(2+DV<-JY0L@8H[*
MWZ)?\$M/V`?$O[)=MXT^('Q3GTQOBIX\TK3M"CTG2;\:A9^%?"MK.NK7&FO=
MQPHESJ-SKTIDG,?F111:;:QQ2?ZP5]/XFYAE&-\,LUJ^)>9<-9QXB2Q$893B
M<BKTJF*K14H.53%\B2</9J:UL]=(IV1\SX*Y;GN5>,?#^'\)<KXMR3PI=/%3
MSC!<08:I1PF%G43Y:>'=1+5RY91:O^\YW>:;9^P=%%%?Q>?Z0A5;RT5W*Y!=
M]S<X!/`;@C&21R>O%6::R*WW@#R#^(Z5,E=QDHJ4X:QNVDGMT\FQ.[3CS.*>
M]OO_`#/./'WPJ^'GQ.T.3PY\1/!WA_QMH38_XEOB73;76+:%_*>#SH([R)S;
M7.QV'FQ[)<G[YKXAU+_@G%\*O"WACXQZ'^S]XF\7_`+4/C)X:A\.:ZWAO5[S
M6/"<$4%^;Q+JW\):S=&*VNY(KC4K222UN;65;36;F.%T)CV_I,5!ZCJ,?A33
M&C=5SR#U/4=#P:][*^)N(,EA"CEN;5\/A%4I5GAW4<\-[6A/VE*H\/*]&<HS
MU3G!Z)+:Z/DL]X$X3XEK_6LYR+#8C'.G5HO$JFHXGV5>'LZL%7AR58J4%;2;
M7]W1'\]/[&O_``3S_:A_8R_:5T/QXA\!?$;X=:MIFJ>!/%NJ:1KUUH^LVGAG
M6;BSO#KQTK7-.C%U<07>CVKRV_G,2MP_E/)A6'QI^U.?VI;C]O63]I>']F+X
MK6-GX'\?>%[CP_!9>#M8\0Z?K_A[P.T5A9WS:QH,=U:AM5LK><KY-PXC@G6-
MBLJ-7];Y@A)SY:9#;@<=#ZCTY].M(;>$LS&-=S`!B,@L!NP&P?F`WMC/3<<5
M^MY?X^9^N*\;Q?Q+D&`XIS7,<K>45W.$L)SX5SNY-T/^7O(Y0YN6UK+8_!\V
M^BMPO/@W+.!N%>(\PX4R3)LZ6>X:*G'&2IXQ0LHKVZC^[51*:5[WN]7O_*-^
MW[\'?BYIOQV\%?MV?"SX;^,K[P9XV'PY^(WEZEX=O8M9\!>+/"XTTG0/'6@1
M;+K3;2[73;8&7(1"\B_:=S1J//\`]HG_`(*-?M*_MJ>"/^%$^&_A!::5::YJ
M&EQ:YI'@&U\1^*?$7BB]L;Q;J+26EDAACTG3)=02U,JR0DQ_9U#WT:EF/]?(
MMX%SMB1<JJ$J-K,B@A49ARR`$X!XYIB6=I&I2.VA12,$)&J[AW#$#YAZYZUZ
M&4^.V!PN!X<I9UX>X+B/-.#8.EE6,Q&)K\^&IJ5X)TTG";II)1V5US)1V/$S
MSZ+&9XO'\7?ZN>+&8\*\/^(E9XO/,#0PM";Q6+:2DZ.)E*-6A0FG44J,4U:2
M5VKH_G&_X)Y?#C]JO]ACQKXU\*?$KX+>(M:^'?Q2^'<WCJ._\+*/$D?A[QGX
M#T;6-8T[0[J6Q,GV35KW3;B]LYH)8Y7>YL]/^RR2JTBS?%O[*-I^V)X3_;*L
M/V@[']G/XLRR>./B+XHU3Q[I3^`/$.G:4/#_`,0=9OKOQ#!'?:K!#%;_`&!-
M2+0%IGP\*F978.M?V&+:VZ`A(44'`PH(`"[=H`!PH&Q<`=,<4XVT!!4Q(5.,
MJ5!7(;>#MZ9W$G\:Y?\`B/..JXOCG,<3P?ELLP\0,#1R_'3@JBBZ%&E4HQ<8
M2<K3<90;][XJ<7<[O^)5<)0PGASEF`\2,VPV5^&F/KYC@82A0J3=7$5:-6=.
M4GRJ,.:G-)I-J-22MJV?RV?ML?L#?ME_M(?M:?%'QQH7PQT^?P;KFI:=IWAW
MQ-JOC3PUIMA<Z#I.A:1I]D9;)M2EOK.4W`NPPDMHP?LT6Q002_W7JO\`P3E^
M,GQV_9>^!/P+^/GQUM?#][\*-?U;4KG_`(1G1/\`A*UUC1S92:1X/T^YU?5;
M[3C_`&CI.B7%_9^<8+B*5)XSY9E0S/\`M0;>$\&-?O%^^=Q));.>#DFE$$*G
M*QJ#G/&1SDGL?4FO%Q_CGQOB\NX2RS"1PF34N"/9O+ZN&I?OJ<Z5+V$9MU>>
M-Y0<G/E23DHNSZ?29/\`1@\/,OS7C7-<QQ&99^_$!U/[4P^)Q]58/$*I76(?
M/AZ:BI2A.,53;G[L+Q5NOY[?LF_\$Y/@)^R/K%WXQ\(GQ;XG^(&I:=-HE_XR
M\3ZV)6?2KAEEFL+;0M)M+6PM[3S=Q4O!/,NX_OS7V]X=\-^'_#%O+8>&O#^C
M^&[![FXNY-.TC3;'2[1[RZD,US?-;Z?"B2RRR$L[E=S-DMD\GK1&@SA0,]<#
MVQ31!".D:]"O_`2<D?3-?F&<Y]GG$>88K-<]S2KF&8XE<DJM2;FY03NKIV4;
M?RQ?+?4_:.&^#N&N$,LPF2\,Y%ALERO`-SHT</#V:IU&DI--\SDJB5IN3<K)
M)7LDE6,#!)+$<C=@@>R@#`QCCC/O4E'2BO+/IPHHHH`****`*=P?WBY_N$?<
M8_*S`L-PX`.T9XZ?G3'B#C(W$`EB=JG.23CG&.I_"KC11N=S*"PZ'G(^G-.V
MKC&./2H49*;DY*2?1PB]/7=_,F45+?7T<H/_`,"C+7[D4@(F3:FX8/"XVC/K
MRH'6HD@W.P90%XVJ!C/(R-V3N!&01W!J^(HUY"@?G_C3RJG.0.>O%*,;<RY(
MQATBN5KU^!-?(3A%RYU%*?=I2>EK6DTI)Z;K;\3$MK2.VN6\H1(&)8JJ/NR>
M"`S<*,=>W?KS6CY89"&^9<<DX()/X9)'3M5G8N,8&*`BCH`.,?AC'\JU?*[W
MYI.2LVY-O[WJA^_S<SJ2DV[MRDYROM9-K2-KZ+9F(\4:NQ6,Y9@S$1%RQ'W<
MLS=/8\?I4MK$RL"LT@4ECM=6XR<X#,3@#G'/&>E:C0QN"&4$'KR?Z&G*BH`%
M4`#H.N/SJ/9TK)<CO'9N<GV[^FP37M))SY[+6_MIO7_!:UO*Y4,8,BN22R;@
M".@!(R.F.<?X8--`R6$@0JQZ<'IT!XY&/7GGK5THI.2.>>?KUI<#T'Y"IY9<
MW.JDHR6]N5*7F_<?ZBY79KW97[INWDO>T^21"J`#"C:`>><YZYR3U&0:9/&D
MH"-G:#_#D'.",@KR#S5D@'L.:0HIP"!QS^7O5\JO*37-*6]_^"G^0.+M&,6J
M<([):?DU^91,"X*Y94*!"5?Y@`&&X$I][+`YSU0'M@PSP@QMLRH^?;M7<I\P
MH[;E5>N],_4GVQJ;%]/U/^--,4;=5!_/_&H<)=:DJJZQERV:[744TOO]"735
MG%12B_Y7*$D_YE)-M/S6OF9ULOE0$9/!RQV,,X]0?F8\T_RQ(%8EV((96^Z5
M."-RAUX.">GK5_RTQC''U/U]:!&BY(7!/7D_3UHE3BTDH145:T7%222Z)Z.Q
M2A&R37,DOM.4I-]W4NI?@9_D*0P+2LS98,&`(/3"NH_=L0>2,$X`/'%1B%71
M_.A+')*J&#MEL@X9!E.YSGKCO6H(HP0P4`@D@]\GK0T:,-K+D=<$G_&FH6<;
M<ONVM[BO'_"[Z?.[\PA'E6C<9O[7--N/I>7O?.W8SXXMD)0K+MSQ'*ZY49)`
M4D<+C`'H`*F>`.JA28VZDJ%+'@@#[O4`\$_K5GR8MH78-H)(';)ZTX(HZ*.!
M@>P]!Z"E.G&7,G"Z?7FDI/;XG_P_S&E+FYIM3FOMN*O+_$OA^X@13DC!((;.
MXJ=P(Y!`'3/\_2HVB0G.,D)MQPJD$8Q\H^OYU;VKZ4;%]!TQ^%-1;2N_9-?R
MV=O-.4=^E[;=2?9WLIOG5[MM;_W;)I<OEY+0IB&,!%`967&PJ=Q4*-H&6&2.
M>_//%.DC&WYAN;MN5F*YXR!VJUL7T_G_`(TFQ",;1CTJ72C*W,E4[N48R;^:
M42TY*+CS:=$FXV7:]V_T\C*,$#E3(DFX#Y)%,L?EE"2"C*V8SR>1C.<'BG)`
M)-RR^85)8G$R-G))!`5<KCH.]:0AC!!"`$`@')X!Z]Z7RTY&T#/7'&?RINF[
M1BG'DCLG33Y5VBW+3\=2>5R</:>^ELW*;E'R3NN;U:78J,BNNU5XSRC,Z`<G
M[H!P!P0?4'!R,BGV\(C8D$DE2",18R2O0QQKCA0,#CCIGFK(10,`<?4_XTH`
D'3^M/D]Y23<?[MHN/R;CS+Y-%)2Y8J4N9QZV<;^MI-/YG__9
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
